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Abstract
Isometric handgrip (IHG) training lowers resting blood pressure (BP) and
improves heart rate variability (HRV) in hypertensives, yet neither the acute responses
nor the effects of training on these responses are known. IHG training effects on 24-hr
ambulatory BP have also yet to be examined. To address these voids, 11 hypertensive
individuals (medicated) performed 4, 2-min IHG contractions at 30% MVC, 3x/wk for 8
wks, and 9 age-matched medicated hypertensives served as controls. At baseline, midand post-training, BP and HRV were assessed prior to and following acute IHG, with BP
monitored for 22 hrs post-IHG. Resting and ambulatory BP were measured on a
separate day. Acute nor chronic IHG exercise altered resting BP or HRV, and 24-hour
ambulatory BP was unchanged with training (all P > 0.05). These findings suggest that
IHG (acute and chronic) does not influence BP or HRV in our population of wellcontrolled medicated hypertensives.
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CHAPTER 1: Introduction and Literature Review

1.1 Hypertension
1.1.1 Introduction
Hypertension (HT) is a medical condition characterized by sustained levels of
high arterial blood pressure (ABP). 1 in 5 Canadians has HT, yet only 43% of people with
HT are aware of their condition (39), thus it is often referred to as “the silent killer”. HT
greatly increases the risk of developing cardiovascular disease (CVD) (89), which is the
leading cause of death in Canada (107). HT is directly responsible for 75% of all stroke
cases (56). Though significant achievements in the treatment and prevention of HT have
been made, the disease remains a prominent health problem in Canada.
1.1.2 Arterial Blood Pressure – Neural, Local and Hormonal Regulation
To better understand the complex pathophysiology of HT, we must first
understand ABP itself and the key regulatory mechanisms that sustain ABP in a healthy
state.
A complete cardiac cycle (1 beat of the heart) exerts 2 distinct pressures on the
body’s arterial system: systolic and diastolic. The pressure the blood exerts on the
arterial system during a cardiac contraction is known as systolic ABP (SBP). In order for
blood flow to occur, it must move from an area of high pressure to an area of low
pressure. Therefore, SBP must be greater than the resistance provided by the arterial
side of the circulatory system to allow an adequate supply of blood flow to meet the
demands and needs of the body’s organs and tissues. Diastolic ABP (DBP), however,
represents the pressure blood exerts on the arterial system when the heart is in the
relaxation phase of the cardiac cycle. These two values are most commonly recorded as
SBP/DBP, with normal ABP being ≤120 mmHg /80 mmHg (115).
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ABP is a tightly regulated system, maintained primarily through neural, local, and
hormonal control. These control mechanisms work together to maintain ABP by
influencing 3 main cardiovascular parameters: total peripheral resistance (TPR), heart
rate (HR), and stroke volume (SV). Cardiac output (CO) is the product of HR and SV
(53), thus changes in CO affect ABP. This is also depicted in the equation for
determining ABP, where ABP equals the product of CO and TPR (53).
Neural Control of Arterial Blood Pressure
The neural control mechanism responsible for cardiovascular control, particular
ABP, is referred to as “central command” (CC) (97). When the body experiences a
cardiovascular stress, CC transmits efferent signals to the cardiovascular control center
(CCC), which integrates the signals and responds by changing the balance of the
autonomic nervous system (ANS). The ANS can be divided into the sympathetic nervous
system (SNS) and the parasympathetic nervous system (PNS). The SNS has a
stimulatory effect on the body, which results in an increase in TPR, HR and SV. The
PNS, however, has a relaxing effect on the body. It decreases TPR, HR and SV. These
systems work simultaneously, where the upregulation of one system over the other
results in physiological changes.
The CCC has a very important role in ABP regulation. Not only does this region
receive signals from CC, it also receives afferent signals from receptors located in the
body that respond to physiological changes. These receptors include arterial
baroreceptors, peripheral chemoreceptors and muscle afferent receptors.
ABP is regulated by the arterial baroreceptors (103). Arterial baroreceptors are
stretch receptors located in the arterial wall of the carotid artery at the carotid sinus and
aortic arch (19, 57). Since baroreceptors are not pressure sensors, but rather stretch
receptors, when pressure exerted on the arterial walls changes, the receptors respond
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not directly to the pressure change, but rather to the conformational change the pressure
induces in the receptor. The CCC is responsible for receiving and responding to these
afferent impulses, which adjusts the ANS to maintain homeostasis.
Peripheral chemoreceptors are sensory receptors responsible for detecting low
oxygen levels in arterial blood (31, 94), as well as high carbon dioxide and hydrogen ion
concentrations (31). These receptors are located in the carotid and aortic bodies and
send afferent signals to the CCC when these conditions occur. The CCC responds to
these signals by altering the ANS, increasing the influence of the SNS to increase ABP,
in order to sustain adequate levels of oxygen and decrease levels of carbon dioxide and
hydrogen ions (31).
Muscle afferent sensory receptors are activated mainly during exercise and send
afferent signals to the CCC to alter autonomic activity (46). There are two main sensory
receptors: 1) mechanoreceptors, which detect stretch in the contracting muscles and 2)
metaboreceptors, which detect metabolic changes within the tissue (71).
Mechanoreceptors and metaboreceptors send afferent signals to the CCC, which in turn
alter the ANS to regulate ABP (71).
Neural regulation of ABP involves many sensory receptors that communicate with
the CCC to alter the ANS. These systems work together to maintain ABP homeostasis
and continue to supply the body with adequate blood flow during times of cardiovascular
stress.
Local Control of Arterial Blood Pressure
Local regulation of ABP involves vasoactive substances that alter blood flow to
meet the metabolic demands of a tissue/muscle (33). Three prominent vasoactive
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regulators responsible for these changes are potassium, adenosine triphosphate (ATP)
derivatives, and endothelium-derived substances.
Potassium is a substance known to accumulate in the muscle during exercise
and slight elevations of potassium have been shown to cause vasodilation, thus causing
increased blood flow to target tissues (33). Potassium is a metabolic byproduct released
from active muscles. Therefore, its accumulation in the muscle’s extracellular fluid is a
signal to the smooth muscle to allow an increase in blood flow to compensate for the
increased metabolic demands of the tissue.
Derivatives of ATP, including adenosine diphosphate (ADP), adenosine
monophosphate (AMP) and adenosine, are all vasoactive substances (33). As ATP is an
essential component in muscle contraction, by-products of its catabolism signal an
increased demand for blood in the exercising muscle. Therefore, when concentrations of
these compounds accumulate, they cause vasodilatation of the vasculature, which
increases blood flow to the exercising muscle (33).
Vascular smooth muscles cells (VSMCs) play an important role in ABP
regulation. These cells control vascular tone via dilation and constriction, thus altering
blood flow and TPR throughout the body. VSMCs form the second layer of the artery
(tunica media), and lay adjacent to the endothelium (inner layer or intima; see Figure 1),
and are controlled involuntarily (34,116), primarily by the autonomic nervous system.
Hormones (e.g., catecholamines, atrial natriuretic factor) and other local chemical stimuli
(e.g., NO, endothelin) may also modulate the contractile state of the VSMCs (116).
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Figure 1: The cellular arrangement of an artery- endothelial cells comprise the inner
layer or lumen of the artery (tunica interna, intima) and the second cell layer is composed
of vascular smooth muscle cells.
With respect to the latter, NO plays a role in locally-mediated vasodilation. NO is
the most potent of the vasoactive substances (109). NO is released by the endothelium
in response to shear stress exerted on the blood vessel walls or the presence of a
chemical stimulus (catacholamines). NO increases the concentration of cyclic guanine
monophosphate (cGMP), which in turn activates cGMP-dependent protein kinase. This
protein dephosphorylates the myosin light chain (MLC) of the smooth muscle, which
inhibits the binding of myosin and actin, thus preventing contraction and promoting
relaxation of the VSMCs (116). Therefore, NO causes a cascade of events that leads to
the relaxation of the VSMCs, which in turn allow the blood vessel lumen to expand. This
expansion decreases the pressure exerted on walls of the blood vessels, and thus
decreases resistance in the vasculature and increases blood flow.
The vasodilatory effects of NO are counterbalanced via the action of
vasoconstricting substances, the most powerful of which is endothelin (ET-1; the smooth
muscle isoform). ET-1 is a compound released by the endothelial cells in response to a
mechanical (i.e., shear stress) or chemical (i.e., angiotensin II) stimulus. There are
specific receptors on the VSMCs that bind ET-1: ETA and ETB. When ET-1 binds to
either of the two receptors on the VSMCs, a cascade of events occurs (93). For
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example, ET-1 induces vasoconstriction via ETA receptor activation. The binding of ET-1
to its receptor causes the activation of phopholipase C (PLC). Active PLC hydrolyzes the
membrane bound protein phosphatidylinositol into two molecules: inositol triphosphate
(IP3) and diacylglyerol. These molecules are classified as secondary messengers, as
they relay the extracelluar signal to the inside of the cell. IP3 binds to the sarcoplasmic
reticulum and causes it to release sequestered Ca2+. ET-1 activates voltage dependent
Ca2+ channels on the plasma membrane causing them to open and allow an influx of
Ca2+ into the VSMC (93). The contractile state of the VSMCs depends on intracellular
[Ca2+] (116). When intracellular [Ca2+] increases, calmodulin and Ca2+ bind to create a
Ca2+-calmodulin complex. This complex activates myosin light chain (MLC) kinase, which
phosphorylates light chain myosin of the VSMCs (115). MLC phosphorylation allows
cross-bridge formation with actin. Myosin ATPase then breaks the high phosphate bond
of ATP, releasing energy and thus allowing smooth muscle contraction to occur (116).
ET-1 also acts via a negative feedback mechanism, whereby the stimulation of
ETB receptors, located on the endothelium, triggers the release of NO (93). This
feedback response causes the dephosphorylation of the MLC and thus promotes
relaxation of the vasculature.
Hormones and other chemical stimuli are also able to inhibit/promote the activity
of MLC kinase and MLC phosphotase. For example, norepinephrine is considered a
vasoconstrictor, as it promotes the release of Ca2+ from the sarcoplasmic reticulum,
promoting Ca2+-calmodulin binding, which in turn causes smooth muscle contraction
(116). In contrast, atrial natriuretic factor (ANF) is classified as a vasodilator as it inhibits
the myosin-actin contractile mechanism and thus promotes vessel relaxation (116).
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Hormonal Control of Arterial Blood Pressure
Many hormones influence the control of ABP; including catacholamines (released
by sympathetic and parasympathetic neurons), renin (released by the kidneys),
aldosterone (secreted by the adrenal cortex), vasopressin (released by the pituitary
gland), and atrial natriuretic peptide (released by the heart). These hormones work in
conjunction with the neural and local ABP control mechanisms to maintain ABP
homeostasis.
SNS neurons release epinephrine and norepinephrine (catecholamines;
neurotransmitters), to stimulate specific cardiovascular responses. Where nerve fibers
come into close contact with the vasculature, synapses are formed. Norepinephrine is
released from the neuron at this synapse. When efferent impulses to these neurons
increase, more norepinephrine is released into the synaptic cleft. Norepinephrine travels
across the synaptic cleft and binds to vascular α-adrenergic receptors, causing
vasoconstriction of the target cell (110). Though some of this compound binds to
receptors on the target cell, it is a fraction of the total amount released from the
presynaptic terminal. Most of the compound undergoes reuptake by the neural terminal,
while another fraction enters the circulatory system. There are also receptors on the
presynaptic terminal that are sensitive to norepinephrine. When there is an excess
release of this neurotransmitter, some binds to the α2-adrenergic receptors located on
the neuron, and further release of norepinephrine is inhibited. This negative feedback
response indirectly causes vasodilatation (84).
The outcome of epinephrine release is mediated by the type of receptor to which
it binds and the location of the receptor. Both α and β-adrenergic receptors respond to
epinephrine. The cardiac response to epinephrine is induced by the stimulation of βadrenergic receptors. This stimulation will result in increased force of contractility and
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increased HR, which therefore increases ABP (70). Vascular α-adrenergic receptors can
also be stimulated by epinephrine, which results in vasoconstriction. This causes an
increase in TPR, which results in an increase in ABP (70).
HR is also regulated by catecholamine activity. As the amount of norepinephrine
released during the stimulation of sympathetic neurons only changes cardiac behavior
fractionally, this pathway requires the activity of secondary messengers, cAMP (32).
Once cAMP is formed, it stimulates β-adrenergic receptors, which causes the sinoatrial
node to increase the rate of impulse generation, thus increasing HR (84). This increase
in HR results in an increase in ABP.
The parasympathetic neurons have only a small effect on vascular resistance.
These nerves only innervate blood vessels in the sacral and cranial regions of the body,
which results in little influence by these neurons (57). Therefore, TPR created by this
vasculature only minimally affects ABP.
Acetylcholine is the neurotransmitter released from parasympathetic nerves.
When acetylcholine binds to muscarinic receptors, located in the cardiac cell membrane,
it causes a decrease in myocardial contractility (8). A decrease in force production by the
myocardium results in decreased ABP. Binding of acetylcholine does not directly
decrease myocardial contractility, but rather inhibits adenylyl cyclase (8). This causes
intracellular cAMP concentrations to decrease, which reduces calcium channel
phosphorylation, causing less calcium channels to open (8). This results in a smaller
influx of calcium, which in turn reduces the amount of calcium released from the
sarcoplasmic reticulum via calcium induced calcium release. This cascading effect
ultimately decreases myocardial contractility. HR is also influenced by parasympathetic
activity. The stimulation of the parasympathetic nerves releases acetylcholine into the
heart, slowing the rate of depolarization. A slower depolarization rate causes HR to
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decrease, resulting in an ABP reduction (114). The sinoatrial node can also become
hyperpolarized when stimulated by parasympathetic nerves. This results in the sinoatrial
node taking a longer time to reach threshold potential, thus slowing the rate of
depolarization and therefore decreasing HR and ABP.
The kidneys are recognized as having the most control over long-term ABP
regulation. They accomplish this through blood volume regulation and vascular tone.
Renin begins the cascade effect by which hormones modulate this system (115).
Renin is a glycoprotein enzyme synthesized in the kidneys. Renin is secreted, via
exocytosis, and interacts with angiotensinogen. Angiotensinogen is cleaved by renin to
form angiotensin I. Angiotensin converting enzyme cleaves angiotensin I, which is the
inactive form of the protein, into angiotensin II, which is the active form of the protein
(11). Angiotensin II is a potent vasoconstrictor, and thus will have the effect of increasing
ABP by increasing TPR.
Angiotensin II stimulates the secretion of aldosterone from the adrenal cortex.
The kidney responds to aldosterone by increasing the reuptake of sodium by the body
(70). When sodium is retained, water follows this change in ion concentration, increasing
fluid volume in the body. This will have a net effect of increasing blood volume, which will
increase ABP.
Thirst is a mechanism by which the body is able to influence fluid intake to
increase or decrease total blood volume. As blood volume contributes to ABP, thirst can
play a role in ABP. The hormone responsible for the stimulation of thirst is angiotensin II.
Once again, this hormone acts to increase ABP by means of increasing fluid intake.
Arterial baroreceptors have an inhibitory effect on thirst, which helps to decrease ABP
(69).
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When ABP is below normal values, vasopressin is released into systemic
circulation by the pituitary gland (41). This hormone has 2 specific roles in regulating
ABP. First, it is able to induce vasoconstriction in the arteries. As discussed earlier,
vasoconstriction of the arteries will cause ABP to increase. The second role of
vasopressin is fluid balance regulation (18). Vasopressin changes fluid balance by
increasing the amount of water excreted by the kidneys.
There are multiple types of receptors with which vasopressin can interact. 2
receptors are of primary concern, as their stimulation induces changes in ABP. V 1 and V2
are the receptors of interest. V1 vascular- termed V1R- is located in the smooth muscle
cells of the vascular tissue. The stimulation of these receptors causes vasoconstriction of
the vasculature. V2 renal- termed V2R- is located in kidney cells and stimulation of these
receptors causes an increase in water excretion into the urine (42). When water
excretion increases, total fluid volume within the body decreases, and subsequently ABP
decreases.
Cardiac atrial cells release atrial natriuretic peptide when the atria experience an
increase in pressure (114). Atrial natriuretic peptide has the opposite effect of
aldosterone. This peptide acts on the kidneys to decrease sodium reabsorption. The
efflux of sodium will pull water into the urine, allowing the kidneys to decrease blood
volume to alleviate rising ABP (70). Atrial natriuretic peptide also has an inhibitory effect
on other hormones. Renin, aldosterone and vasopressin secretion are inhibited by atrial
natriuretic peptide. This inhibition results in a decrease of ABP (4).
1.1.3 Methods of Measuring Arterial Blood Pressure
The most accurate way to measure ABP requires an invasive procedure. A
catheter is inserted into an artery, where a direct continuous intra-arterial measurement
can be acquired. However, as intra-arterial catheter ABP measures require medical
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expertise and often incur side effects such as pain, arterial damage, infection, and/or
edema (48, 88), the technique is not practical in most settings. As a consequence,
numerous indirect ABP measurement techniques have been developed and validated,
including: ausculatory sphygmomanometry, osciollometry, and arterial tonometry.
Ausculatory Sphygmomanometry
The gold standard indirect method of measuring ABP involves the use of a
sphygmomanometer. In this method, an inflatable cuff is placed around the upper arm,
approximately 2-3 cm above the brachial artery (6). The cuff is inflated to a pressure
greater than SBP, usually around 200 mmHg. This ensures cessation of blood flow
through the artery. Air is slowly released from the cuff. A stethoscope placed over the
brachial artery allows the health care professional to detect auditory changes in the
artery. As the pressure in the cuff drops below SBP, around 120 mmHg in normotensive
individuals, Korotkoff sounds can be heard (57). As the cuff deflates further and the
pressure on the artery decreases, more blood is able to flow through the artery, and the
sounds become increasingly louder until they disappear. The sound disappears when
the pressure of the cuff falls below DBP, which represents complete flow of blood
through the artery. This usually occurs around 80 mmHg in individuals with normal ABP
(57). This method measures the pressure within the cuff, not the pressure of the artery
itself and hence is an indirect method (99). This popular method, however, has inherent
limitations, including observer error (particularly the reliance on the observer’s hearing),
improper cuff size (which measures ABP inaccurately), and incorrect measurement
techniques (which result in incorrect values for ABP) (82). This technique requires
specialized training to limit the previously addressed limitations.
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Osciollometry
Osciollometry is another form of indirect ABP measurement and employs the
same preparatory steps of placing a cuff around the upper arm, as described above. This
method does not, however, rely on auditory feedback to determine ABP. Rather, it relies
on oscillatory signals to estimate ABP (101). As pressure in the cuff decreases,
oscillatory signals are collected by a microprocessor within the cuff. Oscillatory signals
begin above the value of SBP and cease below the value of DBP. The maximal
oscillatory signal the device detects is equal to the mean ABP, which is an average of
SBP and DBP (102). The microprocessor applies algorithms to this maximal signal to
calculate SBP and DBP (101). This method only estimates SBP and DBP, and thus may
result in inaccurate measurements of both values.

Arterial Tonometry
Arterial tonometry also measures ABP non-invasively. This technique allows for
the continuous collection of the arterial pressure waveform, giving insight into the
continuous fluctuations in ABP during a cardiac cycle (63). Instead of using a cuff to
occlude blood flow in the brachial artery (as seen with the previous 2 methods), a
pressure sensor is placed on a superficial artery (usually the radial artery (71), which lies
on top of a bone. The principle of arterial tonometry is dependent upon the artery in
question being compressible (35). In order to obtain an accurate pressure waveform, the
pressure sensor must adequately flatten the artery. The Imbert-Fick law states the
internal pressure of a completely elastic spherical body equals the force exerted on this
body, divided by the flattened surface. This law allows for arterial tonometry to estimate
ABP (63). Though this technique gives insight into continuous ABP, it does have some
limitations: positioning of the device must be precise, motion artifacts can interfere with
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the signal, and calibration of the device requires the use of an external measurement
(63).
1.1.4 Pathophysiology and Consequences of Hypertension and Recommendations
for Treatment
HT is defined as a sustained elevation of resting ABP. ABP can be categorized
as normal, pre-HT and HT. Normal values for SBP are ≤120 mmHg and ≤80 mmHg for
DBP (15, 105). A person is classified as having pre-HT when their SBP ranges between
120 -139 mmHg and/or their DBP ranges between 80-89 mmHg (15, 105). HT is
classified as a SBP ≥140 mmHg and/or DBP ≥90 mmHg (15, 105). Stage 1 HT is defined
as SBP between140 - 159 mmHg and/or DBP between 90 - 99 mmHg and Stage 2 HT
as a SBP ≥160 mmHg and DBP ≥100 mmHg (15, 20).
HT can be of known or unknown causes. Essential (primary) HT encompasses
95% of all cases of HT and the cause is unknown (20). In contrast, systemic (secondary)
HT has a known cause, yet only accounts for a small percentage of all cases (20). As
previously discussed, ABP is regulated through neural, local and hormonal control. A
problem in one or more of these regulatory systems may contribute to the development
and maintenance of HT. Essential HT tends to be genetically linked, where salt
sensitivity, renin secretion, and obesity can be potential contributors to the
pathophysiology of HT (20). This form of HT can be treated and/or prevented with
lifestyle modifications (exercise and diet) and/or with pharmacological treatment (20).
Systemic HT is unique in that it can be directly related to a specific physiological
problem. For example, HT is often caused by problems occurring with the endocrine and
renal systems and/or can be improved or even cured through medical therapy or surgery
(20).
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The pathophysiological manifestations and consequences of HT lead to premature death in treated and untreated individuals (20). The risk of developing CVD
doubles for every incremental increase of 20 mmHg and 10 mmHg in SBP and DBP,
respectively (14). HT is mostly associated with increased TPR and normal CO (20).
HT can cause endothelial damage, which is believed to contribute to the
development of vascular diseases, including atherosclerosis (20). Other outcomes of
vascular damage include renal disease and stroke (20). In addition, chronic increases in
TPR cause the heart to continually work harder to overcome this higher resistance and
adequately perfuse the tissue. This can result in ventricular hypertrophy and dysfunction,
and ultimately in overt heart failure (20).
HT is associated with an increase in sympathetic outflow and decreased
parasympathetic activity, including a reduced ability of the autonomic nervous system to
modulate HR (HR variability; HRV) (111), all of which increase the risk of cardiac
mortality (112).
The primary prevention and treatment recommendations for HT include lifestyle
modifications such as diet modification and exercise prescription, particularly in pre-HT
individuals (15). Increased physical activity and dietary changes alone have been shown
to reduce ABP and bring ABP to within the normal range (15). Other lifestyle
modifications include maintaining a normal weight, decreasing dietary sodium intake,
limiting alcohol intake, and following the Dietary Approaches to Stop Hypertension
(DASH) eating plan (a diet containing a large amount of vegetables, fruit and low-fat
dairy products) (15). In some individuals, following the DASH eating plan has been
shown to be as effective as a single anti-HT medication (15). Therefore, lifestyle
modification plays a vital role in the management and prevention of HT.
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Pharmacotherapy is often prescribed if lifestyle modifications alone fail to
decrease ABP to within the normal range (or ABP is morbidly elevated). There are many
medications prescribed to treat HT and depending on the severity of the HT, more than
one medication may be needed to adequately control ABP (15). The main classes of HT
medications are: diuretics, angiotensin converting enzyme inhibitors (ACEIs),
angiotensin receptor blockers (ARBs), β-blockers (BBs), and calcium channel blockers
(CCBs) (15).
Diuretics are recommended as the first type of pharmacological intervention, as
they reduce cardiovascular complications associated with HT (15). The antihypertensive
effects of diuretics are attributed to alterations in kidney function including: increasing the
excretion of chlorine, sodium, potassium and bicarbonate ions in the urine, inhibiting the
reuptake of sodium and chlorine ions by the kidneys, and decreasing uric acid and
calcium excretion in the urine (20).
ACEIs are effective in lowering ABP by preventing the conversion of angiotensin I
to angiotensin II, which as previously described, is a potent vasoconstrictor (20).
Reduction of circulating angiotensin II decreases vasoconstriction, which in turn reduces
TPR and therefore, ABP. Individuals with diabetes are usually prescribed ACEI
medications to protect their kidneys, as diuretics interfere with the normal functioning of
the kidneys (20).
ARBs evoke similar outcomes to ACEIs because they block angiotensin II from
binding to its receptors (20). ARBs inhibit aldosterone secretion and the vasoconstrictive
effects of angiotensin II (20). Inhibition of aldosterone decreases blood volume, while
decreasing vasoconstriction decreases TPR. Both of these outcomes result in TPR
reductions.
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BBs are another type of medication prescribed to lower ABP. These medications
compete with epinephrine for the binding site on β-receptors (20). When BBs bind, they
prevent epinephrine from stimulating the sinoatrial node to increase HR. Ultimately they
decrease the force of cardiac contractility and HR, which result in a reduction of ABP
(20).
The most common class of CCBs used to treat HT are collectively named
dihydropyridine CCBs (20). These types of CCBs act on the smooth muscles in the
vasculature. They induce vasodilation by inhibiting the calcium influx into smooth muscle
that causes vasoconstriction (20). The antihypertensive effect of this medication is a
result of decreased TPR, and thus decreased ABP (20). A potential side effect of these
medications is an increased in HR due to the rapid vasodilation of the vasculature (20).
To avoid such complications, long-acting agents are preferred, as they result in gradual
vascular changes, and prevent the rapid activation of the SNS (20).
Recent evidence suggests that although chronic pharmacotherapy can reduce
ABP to within the normal range, individuals still exhibit high levels of sympathetic outflow
(28), despite this adequate ABP control. This high level of sympathetic outflow may
explain the high rates of morbidity and mortality in individuals medicated for HT (28).
In 2007, it was estimated that Canadians spent over $26 billion dollars on
pharmaceuticals (10), with 20% of this spending accounting for hypertensive medications
(77). While medication is effective in the treatment of HT, mortality rates in the HT
population remain high. Furthermore, pharmacotherapy is effective in less than 50% of
treated patients (74), leaving many unanswered questions surrounding the effectiveness
of pharmacotherapy.
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1.2 Exercise and Hypertension
Exercise effects acute and chronic ABP regulation. As described in the previous
section, physical activity can reduce chronic resting ABP, while the acute alterations in
ABP occur to maintain muscle perfusion and activity. Exercise plays a large role in the
prevention and management of HT, as previously discussed (20). The American College
of Sports Medicine (ACSM) recommends aerobic exercise 3 to 7 times per week for 30
to 60 minutes at an intensity of 30 (for sedentary individuals) to 85% (for regular vigorous
exercising individuals) of an individual’s oxygen reserve to elicit the health benefits
associated with exercise training (2). Resistance exercise is recommended as a
supplement to this aerobic activity (2). The ACSM recommends resistance exercise be
performed 2 to 3 times per week, where one set of 10-15 repetitions are performed for
each of the major muscle groups (20). Currently, there are no ACSM-endorsed
recommendations for chronic isometric exercise training.
1.2.1 Effects of Acute Exercise on Arterial Blood Pressure
Aerobic Exercise
Aerobic exercise (walking, running, swimming, cycling) involves the rhythmic
contraction of muscles for a sustained period of time. At the onset of aerobic exercise
SBP increases linearly, and during high intensity exercise, can reach values of > 200
mmHg (54, 65). This increase in SBP is due to an increase in HR, CO, and blood flow to
insure adequate perfusion of the active muscle (55). The pressor reflex (efferent muscle
signals which causes constriction of the arterioles) also contributes to the rise in ABP.
Active muscles respond to this increase in SBP through vasodilation, helping offset the
rise in ABP (53). This results in a decrease in TPR, to levels less than at rest (53). As
such, SBP does not remain high for the duration of the exercise, and generally
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normalizes around 140-160 mmHg (65). As a result of TPR reductions, DBP changes
minimally with aerobic exercise (65).
Resistance Exercise
Resistance exercise involves both static and dynamic exercise. During the static
portions of the exercise, SBP/DBP have been shown to increase to values above
400/200 mmHg (20). Resistance exercise affects many cardiovascular parameters
including HR, SV, (thus CO) and blood flow (64). As with aerobic exercise, these
parameters change depending on the intensity of the exercise.
During the concentric/eccentric portion of the exercise, blood flow to the
contracting muscle is occluded, due to the mechanical compression of the vasculature
(64). This occlusion causes the ANS to stimulate the SNS to increase CO, which results
in an increase of ABP (64). Other contributors to the increase in ABP include the pressor
reflex and the Valsalva maneuver (breath holds and/or forced exhalations against a
closed airway). The Valsalva maneuver causes an increase in intrathoracic pressure,
which results in an increase in ABP (58). The magnitude of ABP increase is directly
related to the size of the contracting muscle, thus larger muscle masses induce larger
changes in ABP (65).

Isometric Exercise
Acute bouts of isometric exercise (sustained voluntary contraction of a muscle)
have a unique effect on the cardiovascular system. At the onset of isometric exercise,
increased HR, CO and sympathetic outflow are responsible for the initial increases in
SBP and DBP (50, 62).
Isometric muscle contraction results in occlusion of blood flow to the working
muscle, as a result of the compression of the vasculature (62, 64). This induces the
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pressor reflex, which increases sympathetic nervous activity, resulting in an increase in
HR and CO, to ensure adequate blood flow to the contracting muscle (62). If the
Valsalva maneuver is executed, ABP will further increase, due to the increase in
intrathoracic pressure (58).
As muscle force increases, the intensity of the exercise also increases, resulting
in higher levels of ABP (53). The increase in ABP, however, is greater than the ABP
needed to meet the metabolic demands of the working muscle by ensuring adequate
muscle perfusion (53). Both increasing the size of the muscle mass performing the
isometric exercise, and increasing exercise duration, influence ABP directly (53). With
isometric exercise, however, ABP never reaches a steady state, but continues to
increase (53).
1.2.2 Post-Exercise Hypotension
Post-exercise hypotension (PEH) is a unique phenomenon characterized by a
sustained reduction in resting ABP after an acute bout of exercise (85). PEH can be
observed for up to 22 hours following an exercise bout (89). This event is most
pronounced in individuals with HT (59). The average short-term PEH reductions in
resting SBP and DBP are ~15 mmHg and ~4 mmHg, respectively (89).
PEH has predominantly been investigated following bouts of aerobic exercise
(59). Although there is evidence to suggest that resistance exercise elicits a PEH
response; this finding is somewhat equivocal and not without controversy (23, 59) For
example, some studies have shown a prolonged reduction in SBP, but no prolonged
reduction in DBP (63, 64). A study conducted by O’Connor and colleagues (1993) found
no prolonged reduction in ABP following resistance exercise. It is thought that the
observed reductions in ABP post-resistance exercise may simply be due to the
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reperfusion of blood to the working muscles that were previously occluded during muscle
contraction (59). As PEH is described as a prolonged event and as such, some feel that
should not be confused with these described reductions in ABP immediately following
resistance exercise (59).
Consensus in the literature suggests that the mechanisms responsible for PEH
acute bouts of aerobic exercise are decreased vascular resistance and a decrease in
sympathetic nerve activity (17, 26, 36, 44, 59, 85). As previously noted, ABP is the
product of CO and TPR. Therefore, if a decrease in sympathetic nerve activity occurs,
there will also be a decrease in TPR and CO (including HR and SV). It could possibly be
the decrease in sympathetic nerve activity that is responsible for the decrease in
vascular resistance, which would allude to decreased sympathetic nerve activity being
responsible for PEH. The effects of isometric exercise on PEH are unknown.
1.2.3 Effects of Exercise Training on Arterial Blood Pressure
Aerobic Exercise Training
A number of meta-analyses collectively affirm that aerobic exercise training,
using a variety of exercise modalities (walking, running, cycling), frequencies (1 to 7
days/week), durations (30-60 minutes) and intensities (30 to 90% maximum oxygen
consumption), reduces resting ABP in both HT and normotensive individuals (89).
Participants in these studies were between the ages of 18 to 79 years, demonstrating the
effectiveness of aerobic training in reducing ABP throughout the lifespan (89).
Overall, normotensive individuals showed average reductions of 2.6 mmHg and
1.8 mmHg for SBP and DBP, respectively, while HT individuals exhibited larger average
reductions in ABP, with SBP decreasing by ~7.4 mmHg and DBP decreasing by ~5.8
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mmHg following training (89). The observed differences in total SBP and DBP reductions
are most likely the result of initial differences in ABP values.
The specific mechanisms by which aerobic training alters ABP remains elusive,
however, it is thought that an alteration in TPR, rather than CO, is responsible for this
change (89). Vascular changes (e.g., increased endothelial-dependent mediated
vasodilation), structural changes (e.g., increased cross-sectional area of resistance
vessels), and functional changes (e.g., norepinephrine receptor desensitization and
increased NO availability and release) are all likely candidates for aerobic training
adaptations (89). Neural modifications (decreased sympathetic nerve activity) and
genetics may also play a role in aerobic training adaptation (89).
Resistance Exercise Training
A meta-analysis completed by Kelley and Kelley (2000), analyzed resistancetraining data from 11 randomized control trials. They found only small overall reductions
in ABP, with a 2 - 4 mmHg reduction in SBP and a 3 - 4 mmHg reduction in DBP.
However, similar reductions have shown to decrease the risk of stroke and coronary
heart disease (47). Resistance training also improves ABP spikes during exercise (64).
As an individual becomes more advanced/trained in resistance exercise, they exhibit
smaller increases in both SBP and DBP (64).
The mechanisms thought responsible for these ABP reductions following
resistance training are similar to those seen with aerobic training (89), such that
vascular, structural, functional and neural adaptations may be responsible for altering
ABP through inducing changes in TPR (89).
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Isometric Exercise Training
Early studies involving isometric exercise training, examined whole-body
isometric exercise and the effects of training on resting ABP. Kiveloff and colleagues
(1971) observed in unmedicated hypertensives, following 5 to 8 weeks of isometric
training, 3 times per week, decreases in SBP of 4 - 28 mmHg and DBP of 2 - 14 mmHg
(49).
Later studies investigated the benefits of a simpler isometric training protocol:
isometric handgrip (IHG) exercise (118). For example, 8-weeks of IHG training in
normotensive individuals resulted in reductions in resting SBP of 12 mmHg and DBP of
14 mmHg. This protocol involved 4 isometric contractions of the dominant arm for 2
minutes, separated by 3 minutes of rest, at 30% maximum voluntary contraction (MVC),
performed 3 times per week (85). Ray and colleagues (2000) further supported the
effectiveness of IHG training in reducing ABP in normotensive individuals. Using a
similar exercise protocol (4 isometric contractions separated by 5 minutes of rest, 4 times
per week for 5 weeks) they found significant reductions in resting mean ABP (MAP) of 4
mmHg and DBP of 5 mmHg. Although resting SBP decreased by approximately 3
mmHg, this did not yield statistical significance (85). In 2007, a study examining
normotensive individuals and the effects of an 8-week unilateral IHG protocol (consisting
of 4, 30% MVC contractions, sustained for 2 minutes with the non-dominant hand, with 4
minutes of rest between contractions) found similar ABP reductions. Investigators
reported a 4.9 mmHg reduction in SBP with no significant differences in DBP (66). The
clinical impact of IHG training was explored by Taylor and colleagues (2003) who
investigated the effects of 10 weeks of IHG training, performed 3 times per week
(consisting of 4, 30% MVC contractions, sustained for 2-minutes with alternate hands,
each contraction separated by 1 minute of rest) in HT individuals. The findings of this
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study support the benefits of IHG training, showing resting SBP and DBP to decrease by
19 mmHg and 7 mmHg, respectively (111).
McGowan and colleagues (2006) examined the effects of 8 weeks of bilateral
(consisting of 4, 30% MVC contractions, sustained for 2 minutes with alternate hands,
with 1 minute of rest between contractions) and unilateral (consisting of 4, 30% MVC
contractions, sustained for 2 minutes with the non-dominant hand, with 4 minutes of rest
between contractions) IHG training protocols in medicated hypertensives. Subjects
completed IHG training 3 times per week for a total of 8 weeks. No changes in DBP were
found, however, the bilateral training reduced SBP by 15.4 mmHg and the unilateral
protocol reduced SBP by 9.2 mmHg. This study demonstrated both bilateral and
unilateral IHG training programs are able to reduce SBP.
In 2007, a multilevel analysis was performed to amalgamate 3 previous IHG
training studies performed at McMaster University (75). The analysis population involved
medicated hypertensives that had performed either a bilateral or unilateral (as described
in the previous paragraph) training program for 8 weeks (3 times per week). The results
of this multilevel analysis showed combined reductions of 5.7 mmHg and 3.0 mmHg for
SBP and DBP, respectively (75).
Most recently, Millar and colleagues examined the effects of IHG training in
normotensive individuals (72). They used an 8-week, 3 times per week, bilateral training
protocol (as described earlier). This study showed reductions in both SBP and DBP of 10
mmHg and 3 mmHg, respectively. This study further supports the validity that IHG
training in an effective exercise to reduce ABP.
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1.3. Heart Rate Variability
Autonomic modulation of HR (HR variability; HRV) can be estimated by
determining beat-to-beat variations in HR in the time or frequency domain.
Time domain HRV analysis
Common variables used for time domain analysis include, among others, the
standard deviation of all normal R-R intervals (see Figure 2) within an established time
interval, the standard deviation of beat-to-beat pulse interval variations, and the number
of differences of successive R-R intervals (Figure 3) > 50 msec/total number of R-R
intervals.
Frequency domain HRV analysis
Spectral analysis is a noninvansive frequency domain method used to estimate
contributions of the PNS and SNS to short- and long-term oscillations in HR. The most
common algorithms employed for this purpose include fast Fourier transformation (FFT),
autoregressive analysis (AR) and coarse-grain spectral analysis (CGSA).

Figure 2- ECG signal- Depicting the R-R interval used to assess HRV (78).
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Figure 3: Consecutive R-R Intervals- displays the beat number vs. length of heart beat
(R-R) (adapted from 1).
1.3.1 Assessment of Heart Rate Variability
Fast Fourier Transformation
Fast Fourier Transformation (FFT) is a unique form of frequency domain analysis
in that the R-R signal is not filtered prior to processing (5, 87). Once the ECG signal is
obtained, the signal is subdivided into seven equal segments. Each of the segments is
halfway overlapped by adjacent signal segments (37). Signals are often periodic in
nature, which leads to the breakdown of the signal into sinusoidal waves (37). Signals
are often accompanied by spectral noise that must be eliminated to provide a more
accurate analysis. Using the correct parameters is essential because if they are set too
small, they do not provide a good representation of the original signal. Alternatively, if the
parameters are set too high, the signal is accompanied by a great amount of noise and
inaccuracies (92). The signal parameters are determined by applying linear regression
analysis to the entire signal, followed by the subtraction of the linear trend from each of
the individual 7 segments (3, 37, 51). In order to minimize spectral leakage (loss of data)
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within a finite observation and smooth the spectral signal, windowing functions (spectral
analysis; FFT) must be applied (37). The application of a FFT allows the signal to be
easily interpreted and evaluated using a graphical representation of the data (5, 37; See
Figure 4 (1)). The graphical product of the FFT defines the frequency bands: very low
frequency (VLF), low frequency (LF), and high frequency (HF) (3). The LF component
provides insight into the sympathetic modulation of HR, while the HF component
provides insight into the parasympathetic modulation of HR (5, 111). The VLF
component corresponds to non-harmonic noise within the spectrum (111). The ratio of
LF: HF can be examined to give insight into the sympathovagal influences contributing to
the alterations in HR by the autonomic nervous system (111).

Figure 4: FFT spectral analysis- Depicts the VLF, LF and HF peaks of the signal
(adapted from (1)).
Autoregressive Modeling
Autoregression (AR) is a model used to analyze a time series of data (in this
case, R-R intervals) to determine the number, center frequency and powers of the
oscillatory components (52, 76, 87, 90). Similar to FFT, this method of analysis requires
a set of parameters (model order) to establish the frequency spectrum and there are
many techniques available (e.g. Akaike Information Criterion) to determine the correct
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parameters (92). Once the parameters have been selected, Burg’s algorithm is used to
determine the coefficients for AR, which enables power spectrum acquisition (92; See
Figure 5). Like FFT, AR defines the following peaks: very low frequency (VLF), low
frequency (LF), and high frequency (HF), and thus describes the bands of the power
spectrum.

Figure 5: AR spectral analysis- Depicts the VLF, LF, and HF bands of the spectrum
(adapted from 1).

In comparison to FFT, AR models create smoother power spectra with better
frequency resolution from shorter segments of data, only requiring one or more
sinusoidal waves (92). Though FFT and AR models produce similar findings, in
individuals with high HRV, AR tends to overestimate LF and underestimate HF powers
compared to the FFT model of analysis (16).
Coarse Graining Spectral Analysis
Coarse Graining Spectral Analysis (CGSA) allows for more accurate quantitative
analysis by acquiring clearer peaks in the LF and HF components (119). This is
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accomplished by first dividing the total spectral power (TP) into non-harmonic (fractal)
and harmonic (oscillatory) components (81). This type of analysis is particularly useful in
subjects who have reduced harmonic spectral power and preserved non-harmonic power
(i.e., heart failure and hypertension) (81). After the harmonic component is determined,
this component is integrated across the LF and HF ranges. The HF integrated range can
then be normalized to the TP, determined by dividing HF by TP. The LF: HF ratio gives
insight into the autonomic balance in the regulation of HR (119).
1.3.2 Reduced Heart Rate Variability
Reduced HRV increases the risk of cardiac mortality (112). The weight of
evidence suggests that individuals with HT have reduced HRV in the time domain
compared to normotensive subjects (104). There is also data to suggest that HF power
(vagal tone) is reduced (1, 87) and the LF component of the power spectra is augmented
in individuals with HT (32, 87) although this latter finding is equivocal. The discrepant
findings in the LF power spectra may, however, be accounted for by methodological
differences. Reduced HRV is also associated with a number of other CVD risk factors
including aging, smoking, and physical inactivity (21), and diminished HF power and
increased LF power are prevalent in the CVD population as a whole (21).
1.3.3 Treatment of Reduced Heart Rate Variability
As reduced HRV is a known risk for increased cardiac mortality, the benefits of
improving HRV have been speculated upon, however, it is unknown whether improving
HRV decreases the risk of cardiac mortality (1). Pharmacotherapy has been investigated
as a treatment option for reduced HRV.
BBs have been shown to increase HRV in patients after a myocardial infarction
(1). Specifically, the rise of the LF component in the morning hours (due to sleep to wake
transition; increase in sympathetic tone) was blunted (1). HRV has been shown to
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increase with a low-dose of muscarinic receptor blockers (Scopolamine, atropine) (1). In
both post-myocardial infarction patients and those with chronic heart failure,
Scopolamine was shown to significantly increase HRV. Specifically, this medication was
shown to increase vagal tone, which could also be observed, as individuals had a
decrease in heart rate (1). The large scale and long-term effects of these medications
require further investigation (1).
Exercise training, as well as, dietary changes and maintenance of normal weight
are commonly employed interventions aimed at improving autonomic modulation of HR
(15).

1.4 Exercise and Heart Rate Variability
1.4.1 Effects of Acute Exercise on Heart Rate Variability
The effects of acute exercise on post-exercise HRV have been underinvestigated, however, the available evidence supports beneficial changes in HR
modulation following a bout of aerobic exercise. For example, Javorka and colleagues
(2002) observed increased HF power, decreased LF power and an improved LF/HF ratio
following an acute bout of bench step climbs for 12 minutes in healthy normotensive
males (43). The authors attributed these findings to an increase in parasympathetic tone
upon the cessation of exercise. Raczak et al. (2005) investigated the effects of 30
minutes of constant treadmill exercise on post-exercise HRV. Upon cessation of the
exercise, HRV increased (all indices of parasympathetic activity increased) (95).
These results are somewhat equivocal however, as contrary to the findings of the
previous 2 studies, other studies have shown decreases in HRV post-exercise. Healthy,
normotensive, sedentary men were engaged in both interval (45 minutes) and steady
state (time adjusted so participants produced the same amount of work as interval
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exercise) cycling exercise (78). Both protocols decreased post-exercise HRV (TP, LF,
HF; 78). Masters athletes (men and women; regular cyclers) who engaged in 25 - 35
minutes of incremental cycling until a lactate threshold of 4.5mmol was observed showed
a post-exercise decrease in HRV (TP, VLF, LF and HF) compared to pre-exercise
indices (9).
The evidence suggests the mode, intensity and duration of exercise play a role in
post-exercise HRV, and it can be either improved or reduced after an acute bout of
aerobic exercise.
1.4.2 Effects of Exercise Training on Heart Rate Variability
Aerobic Exercise
The effects of aerobic training on HRV have been thoroughly investigated (7, 12,
29, 45, 108), and although the findings are somewhat inconclusive, they appear
population dependent. Although there is data to suggest an improvement in HRV with
aerobic training in patient populations and in older individuals, this has not consistently
been demonstrated in young, healthy populations. For example, in a study examining the
effects of 8-weeks of endurance-based (static cycling and calisthenics) cardiac
rehabilitation on HRV in patients who had experienced a myocardial infarction (61),
investigators noted improved HRV, (increase in HF power and decrease in LF power) in
the exercise group compared to the non-exercising control group (61). These
improvements persisted for 1 year following training, in contrast to the control group, who
still experienced reduced HRV after the 1-year period (61). Furthermore, Stein and
colleagues (1999), revealed significant increases in HRV (increase in TP, LF and VLF)
after a 12-month aerobic training program (3 month initial flexibility training, followed by 9
months endurance exercise (walking, jogging, cycling and rowing), 5 days per week, 4560 minutes, 60 to 85% VO2max) in healthy older individuals. These changes may be
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attributed to the population group, as older individuals have decreased HRV, or to the
longer duration of training. A more recent investigation determined that, 8 weeks of
aerobic training elicited marked increases in HRV (LF power increase (9%) and HF
power increased (11%) in post-menopausal women (45) who performed treadmill and/or
recumbent cycling (3-4 times per week, 120-165 minutes, at 50% VO2max)) (45).
In contrast, Boutcher and colleagues (1995) found healthy middle-aged
individuals who underwent 24 aerobic training sessions (20-30 minutes
walking/jogging/cycling, 3 times per week, at 60% HR range) to have no significant
alterations in HRV. Similar findings were noted in healthy, young, middle-aged men
following 3-months of aerobic training (40 minutes of walking and/or jogging, 3 times per
week, 75 to 80% peak HR) (12). Again, no significant post-training changes in HRV were
observed in this group (12). This lack of change in HRV may be attributed to the
population being examined, as younger individuals have increased HRV compared to
their older counterparts.
Resistance Exercise
The effects of resistance training on HRV have been investigated to a lesser
degree than aerobic training; however, the results continue to support increases in HRV
with exercise in clinical and older populations. In an early study examining the effects of
3 months of resistance training (circuit training, 3 times per week, at a moderate
intensity) in persons with chronic heart failure (100), significant increases in HRV were
observed (increase in HF power and decrease in LF power). More recently, the effects of
16 weeks of resistance exercise (30 minutes circuit training, 8-12 repetitions, 50-80% of
1 repetition maximum, 2 times per week) were examined in women with Fibromyalgia
who had pre-training reductions in HRV (22). Investigators found increased HRV
(increase in TP and HF power) after the training program.
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Isometric Exercise
Few studies have investigated the effects of isometric training on HRV. In 2003,
Taylor and colleagues investigated the effects of 10 weeks of IHG training on HRV in
hypertensive individuals (3 times per week, 4, 30% MVC contractions, sustained for 2minutes with alternate hands, separated by a 1 minutes rest period). This study further
supports the benefits of exercise training on HRV in clinical populations, as the
investigators observed improvements in HF power following the training period (111).

1.5 Ambulatory Blood Pressure and the effects of Exercise Training
Ambulatory ABP gives insight into the 24-hour fluctuations of ABP, and is
reflective of activities of daily living. Although controversial, diagnostic clinical ABP
measurements appear to inaccurately estimate resting ABP, and 40% of the time these
readings are incorrect, as compared to 24-hour ABP measurements (38). Furthermore,
ambulatory ABP is more efficacious in predicting CVD related events than clinical resting
ABP measures (91). The benefits of ambulatory ABP monitoring have made this practice
an increasingly popular tool in the clinical setting (91).
The mean ambulatory values for ABP in normotensive individuals are 135 mmHg
and 85 mmHg (91) for SBP and DBP, respectively, although ambulatory ABP in
normotensive individuals do have diurnal rhythms. These diurnal rhythms can also be
observed in many individuals with HT, however, the ABP mean values in this population
are increased overall (91). Ambulatory blood pressure is highest during the morning
hours (attributed to the change from a sleep to a waking state) and lowest (10 - 20%
lower) during the sleeping hours (91).
The effects of exercise training on ambulatory ABP have been underinvestigated.
Van Hoof and colleagues (113) found healthy males who performed endurance exercise
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for 4 months experienced reductions in daytime DBP by ~5 mmHg. Ambulatory ABP was
shown to decrease by 4.8 mmHg and 7.5 mmHg for SBP and DBP, respectively, in mild
and borderline HT individuals after 6 months of endurance training (106). Palatini and
colleagues (86) also examined the role of exercise training in ABP. Unmedicated HT
individuals (86) were divided into an exercise training group and a control group by selfreported indices of exercise. If subjects reported to participate in aerobic sports, at least
1 time per week, they were included in the training group, and those who did not partake
in such activities, were assigned to the control group (86). Results showed similar SBP
values between the training and non-training groups, however, the training group
exhibited lower DBP (4 mmHg). The training group also had smaller differences in both
day and night ambulatory ABP than the control group (86).
A meta-analysis of 11 studies, conducted by Cornelissen and Fagard in 2005,
examined the effects of ≥ 4 weeks of exercise training (walking, running, cycling) on
ambulatory ABP (13). Daytime SBP and DBP decreased by 3.0 mmHg and 2.4 mmHg
while nighttime ABP decreased 3.3 mmHg and 3.5 mmHg for SBP and DBP,
respectively (13). This study reaffirmed the previous studies, showing endurance
exercise can significantly decrease ambulatory ABP in both normotensive and
hypertensive individuals.

1.6 Summary of Background
CVD is the leading cause of death in Canada, with HT significantly contributing
to the risk of its development. HT is a complex pathophysiological disease, which rarely
can be attributed to a known cause. Individuals with HT have elevated resting and
ambulatory ABP, experience PEH following many forms of exercise, and have reduced
HRV.
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The prevention and treatment of HT include lifestyle modifications and
pharmacotherapy. Many individuals treated with pharmacotherapy remain above the
normal ABP range, yet others remain unaffected. Lifestyle modifications, particularly
exercise, have proven to be a successful means of lowering resting and ambulatory ABP
and improving HRV. IHG training is a novel, non-time consuming, and simple form of
exercise, shown, in individuals with and without HT, to markedly reduce resting ABP.
The transfer of these effects to activities of daily living (i.e., ambulatory ABP), however, is
currently unknown. Furthermore, individuals with HT have shown improvements in HRV
with IHG training; however, the PEH and HRV response post-IHG bout remain unknown,
as are the effects of IHG training on these responses.

1.7 Thesis Objectives
The objectives of this thesis project are 2-fold:
1. To investigate the ABP (PEH) and HRV responses immediately following a bout of
IHG in individuals medicated for hypertension, and to observe the effects of training on
these responses,
2. To replicate previous reductions in resting ABP and improvements in HRV, and
observe the effects of training on 24-hour ambulatory ABP,

1.8 Specific Hypotheses
The substantive hypotheses are:
1. HT individuals will experience PEH following an acute bout of IHG exercise
accompanied by an increase in vagal modulation in HR, prior to training, and it is
expected that these responses will be altered after 8 weeks of training.
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2. Resting and ambulatory ABP will decrease with 8-weeks of bilateral IHG training, and
resting HRV will improve with training.
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2.1 Overview
The general methodology chapter provides an overview of the methods used to
study the effects of isometric handgrip exercise on post-exercise hypotension,
ambulatory arterial blood pressure and heart rate variability in individuals
medicated for hypertension. Although the data was collected in one large study, for the
purposes and ease of knowledge translation and publication, the data has been
separated, and will be presented as 2 manuscripts.
The first, entitled: Acute effects of IHG exercise on arterial blood pressure
and heart rate variability in medicated hypertensives and the influence of training,
and described in detail in Chapter 3, was designed to examine two research questions:
1) Does an acute bout of IHG cause sustained reductions in ABP and improvements in
HRV (specifically improved vagal modulation of heart rate)? and, 2) Does 8-weeks of
IHG training attenuate the acute ABP and HRV responses following a single bout of IHG
exercise? In order to answer the proposed questions, 11 participants trained 3 times per
week for 8-weeks, and 9 individuals served as non-trained ABP controls. Measures of
pre-IHG ABP and HRV, and post-IHG ABPs and HRV were acquired for all participants
at baseline, after 4 weeks of training or control ABP measures (mid-training; week 5),
and following 8 weeks of training or control ABP measures (post-training; week 9).
The second, entitled: Effects of isometric handgrip training on resting and
24-hour ambulatory arterial blood pressure and heart rate variability in individuals
medicated for hypertension, and described in detail in Chapter 4, was designed to
examine two research questions: 1) Does 8-weeks of IHG training reduce resting and
ambulatory ABP in medicated hypertensives? and, 2) Does IHG training improve HRV in
individuals medicated for hypertension? Eleven individuals trained 3 times per week for
8-weeks, and 9 participants served as non-trained ABP controls. Measures of resting

and ambulatory ABP and HR were acquired for all participants at baseline, after 4 weeks
of training or control ABP measures (mid-training; week 5), and following 8 weeks of
training or control ABP measures (post-training; week 9).
The general methodology chapter includes descriptions of the study participants,
the large-scale study design, the IHG training protocol, and the testing methodologies.
These include pre- and post- ABPs and HRV measures, resting ABP, and ambulatory
ABP.
Comprehensive details regarding the study participants, data collection and
analyses protocols, and statistical analyses for the above-noted manuscripts are
described in each of Chapters 3 and 4.
2.1.1 Study design
The University of Windsor Research Ethics Board approved this randomized
controlled study (REB# 09-060; Appendix D). After inquiring about the study, participants
were required to meet with study investigators (Physical Activity and Cardiovascular
Research (PACR) laboratory, Room #240, Human Kinetics Building, University of
Windsor, Windsor, ON, Canada) for an informational meeting and to sign a letter of
information (Appendix E), an informed letter of consent (Appendix F) and a medical
questionnaire (Appendix G). Upon review of the medical questionnaire and
establishment of eligibility, participants returned to the PACR laboratory (Room #240,
Human Kinetics Building, University of Windsor, Windsor, ON, Canada) to undergo
familiarization of all testing procedures.
Following habituation, participants were randomized to the IHG training group or
the non-exercising control group. In order to randomize participants into groups,
GraphPad software was employed to assign participants to the various groups
(GraphPad Prism 5, GraphPad Software Inc, La Jolla, CA, USA). Each participant, on
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entrance into the study, was sequentially assigned a number, thus being assigned to a
group depending on the assignment of the software. Participants assigned to the IHG
training group were instructed on the proper IHG exercise techniques.
After participants were assigned to their experimental group, they underwent 2
days of baseline testing procedures (pre-training), which were repeated by all
participants after 4 weeks of IHG training or ABP monitoring (week 5; mid-training) and
after 8 weeks of IHG training or ABP monitoring (post-training).
2.2 Isometric Handgrip Training
2.2.1 General Description
The IHG device (ZonaPLUS, Zona HEALTH, Boise, ID, USA; see Figure 6) is a
computerized handgrip dynamometer programmed to execute 4 sets of 2-minute
isometric contractions (using alternate hands) at 30% maximal voluntary contraction
(MVC; determined at the onset of each exercise session, on each limb, via electronic
linear load cells contained within each IHG device), each separated by 1-minute rest
intervals (8,10).

Figure 6- Zona handgrip dynamometer
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Participants trained in the seated position with their training arm (which alternated
with each contraction) placed on a table directly in front of them. Their lower arm rested
on the table at a 90° angle from the upper arm. See figure 7 for a picture of the IHG
training position.

Figure 7- IHG training position
2.2.2 Exercise Training Protocol
Participants assigned to the IHG training group trained 3 times per week, for a
total of 8 weeks. Two training sessions per week took place under the direct supervision
of an exercise trainer, and the third session was conducted in the participants’ home.
Participants were provided with detailed instructions to ensure proper at home training,
and were instructed to record their exercise, nutritional, and medication data in exercise
log books to ensure consistency throughout the intervention period (Appendix H).
Each training session took approximately 30 minutes. Prior to the on-site training
session, participants had their ABP measured using brachial arterial osciollometry
(Dinamap ProCare 100, Critikon, Tampa, FL, USA). Participants then performed a bout
of IHG exercise.
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ABP Control Group
Participants randomized to the non-exercising control group visited the laboratory
2 times per week to have their ABP measured. In addition, this enabled acute monitoring
of exercise, nutritional, and medication status throughout the study.

2.3 Outcome Measures
2.3.1 Testing Protocol Procedures
To minimize the influence of external factors on the cardiovascular measures,
participants were asked to refrain from the consumption of alcohol and exercise for 24
hours prior to each testing session, and to avoid caffeine consumption for 12 hours prior
(10). All testing was conducted in the morning, in a quiet, temperature-controlled room,
following a light breakfast. On both testing days, all participants were asked to void their
bladder prior to the testing session to minimize the effects of bladder distension on blood
pressure (4).
2.3.2 Brachial Artery Osciollometry
Brachial artery osciollometry was used to measure pre- and post-IHG ABP and
HR (Chapter 3: Acute effects of IHG exercise on arterial blood pressure and heart rate
variability in medicated hypertensives and the influence of training), and for resting ABP
and HR and 24-hour ambulatory ABP (Chapter 4: Effects of isometric handgrip training
on resting and 24-hour ambulatory arterial blood pressure and heart rate variability in
individuals medicated for hypertension).
Pre-IHG, post-IHG ABP and HR (immediately following, 1 hour and 2 hours postIHG), and resting ABP and HR were measured (Dinamap ProCare 100, Critikon, Tampa,
FL, USA) after 10 minutes of seated rest, whereby participants were instructed to keep
their feet flat on the floor (12). Their right arm was adjusted adjacent to the body at heart
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level and an ABP cuff (23 – 33 cm) was placed around the upper arm to acquire ABP.
Figure 8 shows the resting ABP upper-body and arm position.

Figure 8- Resting ABP body position

Three hour to 22 hour post-IHG ABPs and HRs were measured using an ambulatory
osciollometric ABP monitoring device (Spacelabs 90207 Ambulatory Blood Pressure
Monitor, SpaceLabs Inc., Redmond, WA, USA; Chapter 3: Acute and chronic effects of
IHG exercise and training on post-exercise hypotension and heart rate variability in
medicated hypertensives). Specifically, the upper right arm was secured with the ABP
cuff (cuff size: 24 - 32 cm) and the square monitor was attached with a belt to the
participant’s waist (see Figure 8 for a depiction of monitor placement). This enabled an
additional 20 hours of ABP and HR to be monitored post-IHG exercise (3 to 22 hours
post-IHG), for a comprehensive total of 22 hours post-IHG (11). Finally, 24-hour
ambulatory ABP and HR were assessed via the same oscillometric ambulatory ABP
device (Chapter 4: Effects of isometric handgrip training on resting and 24-hour
ambulatory arterial blood pressure and heart rate variability in individuals medicated for
hypertension).
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Figure 9- Spacelabs ambulatory ABP cuff: Depicts the placement of the ambulatory
ABP cuff on the participant’s right arm. The square monitor was secured on the
participant’s belt loop.
2.3.3 Electorcardiography
Electrocardiography was used to monitor continuous beat-to-beat heart rate (HR)
(Chapter 3: Acute effects of IHG exercise on arterial blood pressure and heart rate
variability in medicated hypertensives and the influence of training). Prior to and following
an acute bout of IHG exercise, HR was measured pre-IHG using standard
electrocardiography (ECG), whereby a set of 3 electrodes was placed on the
participants’ chest. To minimize lead placement errors, the same investigator performed
the ECG setup at all testing sessions (3). All R-R interval HR data was recorded for 10
minutes for later analysis of HRV.
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2.4 Data Analysis
2.4.1 Resting ABP and HR
For resting ABP, pre-IHG and post-IHG (immediately, 1-hour and 2 hours postIHG) ABP and HR measures (Dinamap ProCare 100, Critikon, Tampa, FL, USA), 4 ABP
and HR values were acquired by the same trained investigator following a 10-minute rest
period, where each measure was separated by 2 minutes (14). The latter 3 measures
were averaged and used in the final analysis.
2.4.2 Ambulatory ABP and HR
Twenty hour ambulatory and post-IHG ABP and HR (3 hours to 22 hours postIHG; Spacelabs 90207 Ambulatory Blood Pressure Monitor, SpaceLabs Inc., Redmond,
WA, USA) were recorded 2 times per hour during daytime hours (6 am – 10 pm), and 1
time per hour during nighttime hours (10 pm – 6 am) (7). Values were averaged during
each hour, time period (daytime and nighttime), and during the entire 24-hour ambulatory
period.
2.4.3 Pre- and Post-IHG HR for HRV analysis
As mentioned above in the section entitled: Electrocardiography, 10 minutes of RR interval HR data was recorded prior to and following a bout of IHG for later analysis of
pre- and post-IHG HRV. HR signal output was sampled at a frequency of 1,000 Hz. The
analogue signals were converted to digital signals using a data acquisition board
(PowerLab 8/30, ADInstruments Inc., Colorado Springs, CO, USA) for off-line beat-tobeat analysis. Ensemble averages of 256 beat sequences were taken from a minimum
time series of 400 beats (9). Ectopic beats were edited and replaced via linear
interpolation from adjacent cardiac cycles (9). Only tracings with ≤5% ectopy-corrected
beats were accepted for analysis (9), therefore 2 of the 20 participants were excluded
from the HRV analysis. To determine HRV, R-R (i.e. pulse) intervals obtained during the
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baseline 10-minute data acquisition period were submitted to coarse graining spectral
analysis (CGSA)(9,15).
CGSA is a non-invasive frequency domain analysis method used to estimate
contributions of the PNS and SNS to short- and long-term oscillations in HR. The output
of the CGSA analysis defines the following frequency bands: very low frequency (VLF),
low frequency (LF), and high frequency (HF) (2). The VLF component corresponds to
non-harmonic noise within the spectrum (13). The LF component provides insight into
sympathetic modulation of HR, while the HF component provides insight into vagal HR
modulation (1, 13). The ratio of LF:HF, although controversial, is said to provide insight
into the sympathovagal influences contributing to the alterations in HR by the autonomic
nervous system (13). The ratio of HF:TP provides information regarding the
parasympathetic modulation of HR (9). CGSA allows for more accurate quantitative
analysis of HRV by acquiring clearer peaks in the LF and HF components of the power
spectrum (15). This type of analysis is particularly useful in clinical populations who have
reduced harmonic spectral power and preserved non-harmonic power, such as those
with hypertension (5).
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CHAPTER 3: Acute effects of IHG exercise on arterial blood pressure and
heart rate variability in medicated hypertensives and the influence of
training
(To be submitted to: Medicine and Science in Sport and Exercise)

Introduction:
Hypertension (HT), a disease characterized by sustained elevations in resting
arterial blood pressure (ABP) and autonomic dysfunction (40), afflicts approximately 972
million people worldwide (11). Considerable attention has been given to the beneficial
effects of aerobic and resistance exercise on reducing resting ABP in individuals with HT
(7,12,15,35,36,41). Meta-analyses of aerobic training studies suggest average
reductions of ~7 and ~6 mmHg in SBP and DBP, respectively (36), and average
reductions of ~3 and ~4 mmHg in SBP and DBP, respectively, following resistancetraining interventions (18) in this population. Based on the weight of the evidence,
current guidelines put forth by the American College of Sports Medicine for individuals
with hypertension recommend aerobic exercise (moderate-intensity for 30 - 60minutes)
most days of the week and resistance exercise (1 set of 8 to 12 repetitions for the major
muscle groups) 2 - 3 days per week (1). The mechanisms thought responsible for
training-induced hypotension include vascular, structural, functional and neural changes
that alter ABP by primarily inducing changes in total peripheral resistance (TPR; 36).
With respect to acute exercise, post-exercise hypotension (PEH), a phenomenon
defined by a prolonged reduction in ABP following an acute bout of exercise, has been
observed for up to 22 hours post-exercise and is most pronounced in those with
hypertension (36). These acute exercise-induced changes in ABP not only offer the
potential benefit of short-term ABP control by providing temporary reductions in daily
ABP, but also offer insight into the pathophysiology of HT and the subsequent response
to different modes of exercise.
PEH has predominantly been investigated following bouts of aerobic exercise,
and has been observed following 10 to 170 minutes of a variety of aerobic exercises
(walking, running, cycling; 19). The average short-term PEH reductions in resting ABP
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are ~10/~7 mmHg, in SBP and DBP respectively (20). Although there is evidence to
suggest that resistance exercise elicits a PEH response, this finding is not without
controversy (8,20). For example, some studies have shown a prolonged (>2hrs)
reduction in SBP, but no prolonged reduction in DBP (21,24), while others have found no
post-exercise ABP alterations (33). Furthermore, some believe that the observed
reductions in ABP post-resistance exercise may simply be due to the reperfusion of
blood to the working muscles that were previously occluded during muscle contraction
(20). Consensus in the literature suggests that the mechanisms responsible for PEH are
likely multi-faceted, and include a reduction in vascular resistance and/or decreases in
sympathetic nerve activity (5,9,12,17,20,34).
A more novel form of exercise training, isometric handgrip (IHG) training (four, 2minute sustained contractions at 30% maximal voluntary contraction (MVC), separated
by a timed rest period, 3x/week for 8 - 10 weeks) is a less time consuming exercise
repeatedly shown to reduce resting ABP (19,26,27,38). Recently, a meta-analysis
supported bilateral IHG training as an efficacious way to attain significant exerciseinduced ABP reductions (~5 and ~3 mmHg in SBP and DBP, respectively) in non-clinical
(young healthy individuals) and clinical populations (hypertension) (19). Although the
acute effects of IHG on post-IHG ABP in individuals with hypertension have not been
thoroughly investigated, in a population of 18 older (70 ± 5 years) healthy adults (9
females), a post-IHG reduction of ~3 mmHg in SBP was observed 5 minutes post-IHG
(30).
In addition to the ABP-specific effects of acute and/or chronic aerobic, resistance
and isometric exercise, the broader scale effects of exercise on autonomic function have
been examined. Spectral analysis of heart rate variability (HRV) is a popular noninvasive tool used to assess autonomic function, and provides insight into the autonomic
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modulation of heart rate (HR) (40). HRV assessment has been widely employed under
resting conditions, and following acute and chronic exercise, in both non-clinical and
clinical populations, including those hypertensive individuals with compromised nervous
systems. Coarse graining spectral analysis (CGSA) is a non-invasive frequency domain
analysis method used to estimate contributions of the parasympathetic and sympathetic
nervous systems to short- and long-term oscillations in HR. CGSA yields two
components, harmonic and non-harmonic components, with the latter representing
fractal noise. The harmonic portion of the spectrum can further be subdivided into 3 main
power components: very low frequency (VLF; harmonic noise), low frequency (LF;
primarily represents sympathetic neural oscillations of HR), and high frequency (HF;
indicative of vagal modulation of HR; 2). Total power (TP) represents the complete
power of the harmonic spectrum (2). The ratio of LF:HF, although controversial, is said to
provide insight into the sympathovagal influences contributing to the alterations in HR by
the autonomic nervous system (40). The ratio of HF: TP provides information regarding
the parasympathetic modulation of HR (27). CGSA allows for more accurate quantitative
analysis of HRV by acquiring clearer peaks in the LF and HF components of the power
spectrum (42). This type of analysis is particularly useful in clinical populations who have
reduced harmonic spectral power and preserved non-harmonic or fractal power, such as
those with hypertension (32).
The effects of acute exercise on HRV have been under-investigated and the
available data provides evidence both for and against acute changes in HR modulation
immediately following an exercise bout. For example, with respect to aerobic exercise,
Javorka and colleagues (16) observed increased HF power and decreased LF power
following an acute bout (12 minutes) of bench step climbs in 17 healthy normotensive
males (20 ± 0.2 years) (16). The authors attributed these findings to an increase in
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parasympathetic tone upon the cessation of exercise. Similarly, the findings of Raczak et
al. (38), who investigated the effects of 30 minutes of constant treadmill exercise on
post-exercise HRV in 18 healthy men (20 - 24 years old), support augmented
parasympathetic activity following aerobic exercise (38). In contrast, other studies have
shown decreases in post-exercise HRV. A population of 10 healthy, normotensive,
sedentary men (24.6 ± 0.6 years) who engaged in both interval (45 minutes) and steady
state (time adjusted so participants produced the same amount of work as interval
exercise) cycling exercise, on separate occasions, exhibited decreases in spectral
indices of autonomic function (LF, HF, TP; 31). In accordance with these findings, 13
masters athletes (men and women; regular cyclers; 52.1 ± 3.3 years) who engaged in 25
- 35 minutes of incremental cycling until a lactate threshold of 4.5 mmol was observed,
showed post-exercise decreases in indices of sympathetic, parasympathetic, and total
autonomic nervous system function (TP, VLF, LF and HF; 4).
Few studies have investigated the acute autonomic responses to resistance
exercise, yet like aerobic exercise, the findings are somewhat equivocal. Rezk and
colleagues (39) investigated the effects of whole body resistance exercise (3 sets of 20
repetitions) on acute HRV in 17 healthy men (n = 8) and women (n = 9) (~23 years old),
and observed increases in LF, reductions in HF, and no change in TP (39). In contrast,
Heffernan and colleagues (14) investigated the effect of whole body resistance exercise
(3 sets of 10 repetitions) on acute HRV in 14 healthy young men (21 - 29 years old), and
observed reductions in TP, LF, and HF (14).
To our knowledge, only one study has investigated the acute effects of a bout of
IHG on HRV. Millar and colleagues (30) recently found that an acute bout of bilateral IHG
(4, 30% MVC contractions, sustained for 2-minutes with alternate hands, separated by a
1-minute rest period) improves vagal modulation of HR in 18 healthy, older (70 ± 5
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years) individuals (females = 9). As this study was performed in normotensive
individuals, further investigation of the effects of acute IHG on HRV in individuals with
hypertension is needed.
Currently, there are no studies investigating the effects of exercise training on the
acute HRV responses to a bout of aerobic, resistance or isometric exercise.
The present study was designed to address the following research questions: 1)
Does an acute bout of IHG cause sustained reductions in ABP (PEH) and improvements
in vagal modulation of HR in individuals with HT? and, 2) Does 8-weeks of IHG training
alter these responses? We hypothesized that an acute bout of IHG would elicit a PEH
response and improve vagal modulation. We further hypothesized that we would see an
attenuated post-training PEH response, as PEH has been attributed to alterations in
autonomic function, we also expected that post-IHG increases in vagal modulation of HR
(30) would be attenuated with training.
Participants and Methods:
Participants. Twenty-five hypertensives, all of who were receiving
pharmacotherapy to treat their hypertension and who had been medicated for at least 4
months, participated in this investigation. Five participants voluntarily withdrew from the
investigation (2 in IHG training group, 3 in the control group), as time commitments
interfered with study participation. Participants were excluded if they had diabetes, a
paced heart rhythm at rest, frequent ventricular premature heartbeats, heart failure, or if
they had any physical limitation that would have prevented them from performing IHG
exercise. Vasoactive medications, external exercise sessions, and nutritional status
remained unchanged throughout the investigation. Participant characteristics are
presented in Table 1. The Research Ethics Board of the University of Windsor approved
the investigation, and all participants provided written, informed consent.
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Table 1: Baseline characteristics of participants
Participants

All
(N = 25)

Training Group
(n = 11)

Control Group
(n = 9)

Females (n)

13

4

6

Age (years)

61 ± 8.2

60.0 ± 8.5

62.7 ± 6.1

BMI (kg/m )

30.8 ± 7.2

31.7 ± 7.5

31.0 ± 8.8

Systolic Blood Pressure (SBP; mmHg)

114.6 ± 11.3

113.9 ± 12.7

117.8 ± 14.3

Diastolic Blood Pressure (DBP; mmHg)

67.5 ± 10.3

60.7 ± 11.6

67.5 ± 4.2

Heart Rate (beats/min)

66.9 ± 10.8

62.8 ± 8.5

69.5 ± 15.3

Diuretic

2

2

1

Angiotensin Converting Enzyme (ACE)

3

1

1

Aldosterone Receptor Blocker (ARB)

3

1

1

Calcium Channel Blocker (CCB)

3

2

0

Diuretic + ACE

1

1

0

Diuretic + ARB

3

1

1

ACE + Beta Blocker (BB)

3

1

1

ARB + CCB

1

0

1

ARB + BB

1

1

0

Diuretic + ACE + BB

2

1

1

Diuretic + ARB + BB

1

0

1

Diuretic + ARB + CCB

1

0

0

Diuretic + ARB + CCB + BB

1

1

0

2

Medication: (n)

Values are mean ± S.D.

All participants completed a medical questionnaire, and were habituated to the
testing procedures. Following habituation, participants were randomized to an IHG
training group or a non-exercising control group (GraphPad Prism 5, GraphPad Software
Inc, La Jolla, CA, USA). Participants assigned to the IHG training group were instructed
on the proper IHG exercise techniques.
Study design. This investigation employed a between-subject repeated
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measures design. ABP and HRV were measured prior to and following a bout of IHG
exercise (4 sets of 2-minute isometric contractions (using alternate hands) on a
programmed handgrip dynamometer (ZonaPLUS, Zona HEALTH, Boise, ID, USA) at
30% MVC, each separated by 1-minute rest intervals (26,27,29), and were assessed at
baseline, and after 4- and 8- weeks of IHG training (or no training for the control group).
Exercise training protocol. Participants assigned to the IHG training group
trained 3 times per week for 8 weeks using the above-described IHG protocol. Two
training sessions per week took place under the direct supervision of an exercise trainer,
and the third session was conducted in the participants’ home. Participants were
provided with detailed IHG instructions to ensure proper at home training. To establish
similar face time with study investigators, participants randomized to the non-exercising
control group visited the laboratory 2 times per week to have their resting ABP measured
(29).
Testing protocol. All data was acquired while participants were seated with their
right arm adjusted adjacent to the body at heart level and their feet flat on the floor (37).
All IHG bouts were performed with the participant in the seated position with their training
arm (which alternated with each contractions) placed on a table directly in front of them.
Their lower arm rested on the table at a 90° angle from the upper arm. All testing was
conducted in the morning, in a quiet, temperature-controlled room, following a light
breakfast, a 24-hour abstinence from alcohol and exercise and a 12-hour abstinence
from caffeine (27). Participants were asked to void their bladder prior to all testing
session to minimize the effects of bladder distension on blood pressure (7).
A schematic of the testing protocol is depicted in Figure 10. In brief, prior to an
acute bout of IHG exercise (4 sets of 2-minute bilateral isometric contractions at 30%
MVC, each separated by a 1 minute rest period; ZonaPLUS, Zona HEALTH, Boise, ID,
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USA) (26,27,40), pre-ABP and HR were measured in the right arm using brachial artery
osciollometry (Dinamap ProCare 100, Critikon, Tampa, FL, USA; cuff 23–33 cm) after 10
minutes of seated rest (37). R-R interval HR data was recorded for 10 minutes for later
analysis of pre-IHG HRV. R-R intervals were acquired using standard
electrocardiography (ECG), whereby a set of 3 electrodes was placed on the
participants’ chest. To minimize lead placement errors, the same investigator performed
the ECG setup at all testing sessions (3). Following this data collection period,
participants performed an acute bout of IHG exercise. Immediately following the last rest
interval, HR was recorded for 10 minutes for later assessment of post-IHG HRV, and
ABP and HR were re-assessed. ABP and HR were evaluated after 1 hour and 2 hours
post-exercise in the laboratory setting (Dinamap ProCare 100, Critikon, Tampa, FL,
USA; 21). Following the final in-house ABP assessment, an additional 20-hours of postIHG ABP and HR were acquired (Spacelabs 90207 Ambulatory Blood Pressure Monitor,
SpaceLabs Inc., Redmond, WA, USA) to allow for a comprehensive 22 hour postexercise evaluation of ABP and HR period to be captured (post-IHG ambulatory ABP
and HR; 36).
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Figure 10- Testing protocol schematic

Data Analysis:
Pre-IHG ABP and HR and on-site post-IHG ABP and HR (immediately, 1
hour, and 2 hours post-IHG): Four pre-IHG ABP and HR values were acquired, each
separated by 2 minutes (Dinamap ProCare 100, Critikon, Tampa, FL, USA) by the same
trained investigator following a 10-minute rest period (42). The latter 3 measures were
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averaged and used in the final analysis (42). Following a bout of IHG exercise, ABP and
HR were again acquired, using the same technique previously described.
Off-site post-IHG ABP and HR: Post-IHG ABPs and HRs were recorded 2 times
per hour during daytime hours (6 am – 10 pm), and 1 time per hour during nighttime
hours (10 pm – 6 am) over the time period spanning 3 hours to 22 hours post-IHG
exercise using an ambulatory brachial artery oscillometric device (Spacelabs 90207
Ambulatory Blood Pressure Monitor, SpaceLabs Inc., Redmond, WA, USA) (22). Values
were averaged during each hour, during each time period (daytime and nighttime), and
during the entire 20-hour ambulatory period.
Pre- and Post-IHG HRV analysis: Beat-to-beat HR was acquired pre- and postIHG using standard electrocardiography (ECG), as previously described (3). HR signal
output was sampled at a frequency of 1,000 Hz. The analogue signals were converted to
digital signals using a data acquisition board (PowerLab 8/30, ADInstruments Inc.,
Colorado Springs, CO, USA) for off-line beat-to-beat analysis. Ensemble averages of
256 beat sequences were taken from a minimum time series of 400 beats (28). Ectopic
beats were edited and replaced via linear interpolation from adjacent cardiac cycles (28).
Only tracings with ≤5% ectopy-corrected beats were accepted for analysis (28), thus 2 of
the 20 participants (both of whom were in the training group) were excluded from the
HRV analysis. To assess HRV, these R-R (i.e. pulse) intervals were then submitted to
CGSA (28,43).
Statistical Analysis:
One-way ANOVAs (group) of baseline pre-IHG ABP, pre-IHG HR and pre-IHG
HRV were employed to determine if baseline differences existed between the training
and control groups at baseline. As no differences were revealed (P ≥ 0.05), two-way
ANOVAs (group x phase) with repeated measures (time) were used to analyze pre-IHG
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to post-IHG alterations in ABP (SBP and DBP), HR and HRV (VLF, LF, HF, TP, LF:HF
ratio, HF:TP ratio). Where applicable, post-hoc analyses were conducted using pairedsample t-tests, which used Bonferroni corrected alpha levels.
All data was re-assessed after separately controlling for, as between subject
factors, gender (male or female), medication (single or multiple medications) and
baseline ABP (controlled to within the normal range (≤120/80 mmHg) or uncontrolled
(≥120/80 mmHg)).
Statistical significance was set at P ≤ 0.05. Analysis of data was completed using
IBM (PASW) SPSS Statistics 18 (SPSS Inc., Chicago, IL, USA).
Results:
Acute cardiovascular effects of IHG exercise
Immediately following a bout of IHG exercise, analyses of variance revealed no
significant differences in SBP or DBP pre- to post-IHG (all P ≥ 0.05) in either the IHG
training (Pre-IHG: 118 ± 14 and 67± 4 mmHg to Post: 117 ± 13 and 70 ± 6 mmHg in SBP
and DBP, respectively), or control group (Pre-IHG: 114 ± 13 and 61 ± 12 mmHg, PostIHG: 114 ± 10 and 62 ± 10 mmHg in SBP and DBP, respectively).
In both groups, SBP was significantly elevated above pre-IHG levels from 2 - 7
hours following acute IHG (Training: 126 ± 16 mmHg, 134 ± 11 mmHg, 133 ± 17 mmHg,
132 ± 11 mmHg, 132 ± 12 mmHg, and 133 ± 16 mmHg, respectively; Control: 126 ± 14
mmHg, 141 ± 13 mmHg, 139 ± 14 mmHg, 131 ± 13 mmHg, 129 ± 14 mmHg, and 126 ±
19 mmHg, respectively) and again from 18 - 22 hours post-IHG (Training: 122 ± 10
mmHg, 130 ± 10 mmHg, 127 ± 14 mmHg, 124 ± 14 mmHg, and 124 ± 14 mmHg,
respectively; Control: 133 ± 18 mmHg, 135 ± 19 mmHg, 135 ± 23 mmHg, 133 ± 20
mmHg, and 131 ± 18 mmHg, respectively) (all P ≤ 0.005; Figure 11).
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Figure 11: The 22-hour SBP response to acute IHG exercise. Hour 0 denotes preIHG SBP value. * Significantly different from pre-IHG values. P ≤ 0.005; N = 20.

From 1 - 8 hours following IHG exercise, DBP remained significantly elevated
above pre-IHG DBP values (P ≤ 0.003) in both groups (Training: 72 ± 5 mmHg, 76 ± 10
mmHg, 78 ± 10 mmHg, 78 ± 14 mmHg, 79 ± 10 mmHg, 80 ± 11 mmHg, 80 ± 11 mmHg,
and 79 ± 13 mmHg, respectively; Control: 63 ± 9 mmHg, 66 ± 9 mmHg, 84 ± 12 mmHg,
76 ± 12 mmHg, 72 ± 11 mmHg, 70 ± 7 mmHg, 71 ± 9 mmHg, and 66 ± 9 mmHg,
respectively). At 19 - 22 hours post-IHG, there was a significant increase in DBP when
compared to pre-IHG DBPs (Training: 77 ± 13 mmHg, 75 ± 14 mmHg, 76 ± 15 mmHg,
and 77 ± 10 mmHg, respectively; Control: 76 ± 18 mmHg, 77 ± 15 mmHg, 79 ± 13
mmHg, and 76 ± 16 mmHg, respectively; P ≤ 0.001). The 22-hour post-IHG SBP and
DBP responses are shown in Figures 11 and 12, respectively.
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Figure 12: The 22-hour DBP response to acute IHG exercise. Hour 0 denotes preIHG DBP value. * Significantly different from pre-IHG values. P ≤ 0.003; N = 20.

HR was significantly reduced immediately post-IHG compared to pre-IHG HR (P
< 0.001) in both the training (Pre-IHG: 69 ± 17beats/min to Post-IHG: 66 ± 15beats/min
and control groups (Pre-IHG: 63 ± 9beats/min to Post-IHG: 60 ± 9beats/min). Post-IHG
HR remained significantly lower than pre-IHG values for 2 hours following the IHG
exercise (Training: 63 ± 12beats/min, and 64 ± 16beats/min; Control: 59 ± 9beats/min,
59±11beats/min; P < 0.001). HR returned to pre-IHG levels for the remainder of the test
period (3 - 22 hours post-IHG; all P ≥ 0.005). The 22-hour post-IHG HR responses are
shown in Figure 13.
All data was re-assessed after separately controlling for gender, medication, and
baseline ABP, and no significant effects were revealed (all P ≥ 0.05).
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Figure 13: The 22-hour HR response to acute IHG exercise. Hour 0 denotes the preIHG HR value. * Significantly different from pre-IHG values. P < 0.001, N = 20.

Following an acute bout of IHG exercise, analyses of variance of the harmonic
components of HRV (VLF, LF, HF, TP, LF/HF, and HF/TP) revealed no significant effects
(all P ≥ 0.3) (Table 2).
Effects of IHG training on acute cardiovascular responses
Acute ABP and HR responses to IHG were measured following both 4- and 8weeks of IHG training (or no-training for the control group). After 4-weeks of IHG training,
the SBP response to IHG in both groups was similar to baseline measures. Immediately
following IHG exercise, SBP remained unchanged from pre-IHG SBP values (P = 0.3).
From 1 - 7 hours and 16 - 22 hours post-IHG, SBP was significantly elevated compared
to pre-IHG SBP values (P ≤ 0.002). Following 8-weeks of IHG training, the SBP
response to IHG exercise remained similar to the responses observed at baseline and 4weeks post-training. Again, SBP remained unchanged from pre-IHG values immediately
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following an acute bout of IHG, yet it was significantly elevated above pre-IHG values
from 1 - 7 hours and 17 - 20 hours post-IHG (P ≤ 0.002).
Following 4-weeks of IHG training (or no-training for the control group), post-IHG
DBP did not significantly change from pre-IHG DBP values (P = 0.1) in either group.
Similar to pre-training, from 1 to 7, 15 to 17, and 19 hours post-IHG, there was a
significant increase in DBP, as compared to pre-IHG DBP values (P ≤ 0.005). Following
8-weeks of IHG training (or no-training for the control group), DBP immediately following
IHG was significantly increased when compared to pre-IHG DBP values (P = 0.003).
During the first hour post-IHG, DBP returned to pre-IHG values. However, DBP again
increased significantly from pre-IHG levels from 2 - 7 and 18 - 20 hours post-IHG (all P ≤
0.002).
Similar to pre-training, HR was significantly reduced following a bout of IHG
exercise (P = 0.002) in both training and control group following 4-weeks of IHG training.
The reduction in HR was only observed immediately following the IHG bout, as 1 - 22
hour post-IHG HR remained unchanged from pre-IHG HR values (P ≥ 0.005). Posttraining there were no significant changes in HR, following an acute bout of IHG for
either group, at any time point.
Two-way ANOVAs of mean 24-hour ambulatory ABP and HR, nighttime ABP and
HR, and daytime ABP and HR revealed no significant main effects or interactions (P ≥
0.6) (Data not presented).
With respect to HRV, significant differences in pre- to post-IHG VLF, LF, HF, TP,
LF:HF ratio, or HF:TP ratio were not observed (P ≥ 0.05) in the training group following
4- or 8-weeks of IHG training, when compared to the non-exercising control group. For
HF power, however, there was a significant interaction between group and phase (P =
0.05) (Table 2), yet post-hoc analysis revealed no significant difference between pre-
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and post-IHG alterations in HF power at baseline, after 4-weeks of training, or after 8weeks of training (all P ≥ 0.07).
Table 2: HRV indices pre- and post-IHG at baseline, after 4- and 8- weeks of training
Baseline

After 4-weeks of IHG training

After 8-weeks of IHG training

Pre-IHG

Post-IHG

Pre-IHG

Post-IHG

Pre-IHG

Post-IHG

Training

203.7 ± 275.0

295.3 ± 547.9

99.2 ± 86.0

110.7 ± 83.1

113.0 ± 132.0

75.7 ± 52.3

Control

158.0 ± 122.7

64.6 ± 71.2

99.4 ± 86.2

59.8 ± 45.9

98.6 ± 107.7

101.2 ± 100.9

Training

86.9 ± 144.1

120.1 ± 193.4

50.7 ± 33.6

64.2 ± 77.4

47.7 ± 48.3

40.0 ± 30.7

Control

108.2 ± 120.6

53.4 ± 77.4

76.2 ± 64.3

82.7 ± 123.8

47.7 ± 61.3

103.9 ± 135.6

Training

65.0 ± 103.6

64.8 ± 92.1

102.7 ± 119.6

106.2 ± 132.8

83.8 ± 109.1

165.1 ± 240.1

Control

93.0±124.0

45.3 ± 48.8

41.5 ± 33.2

28.2 ± 24.9

73.1 ± 91.5

109.1 ± 112.8

355.6 ± 486.7

480.2 ± 766.2

252.7 ± 211.8

281.1 ± 213.0

244.4 ± 252.6

280.9 ± 266.7

359.2 ± 323.7

163.3 ± 140.3

217.1 ± 124.1

170.7 ± 143.6

219.4 ± 172.9

314.1 ± 245.0

2.1 ± 2.1

5.1 ± 6.9

0.8 ± 0.8

0.9 ± 0.6

3.2 ± 5.6

2.0 ± 4.3

3.1 ± 6.1

3.7 ± 8.1

3.8 ± 4.9

7.9 ± 15.7

1.6 ± 2.5

1.4 ± 1.5

Training

0.3 ± 0.2

0.4 ± 0.3

0.4 ± 0.2

0.4 ± 0.2

0.4 ± 0.3

0.4 ± 0.2

Control

0.2 ± 0.1

0.4 ± 0.4

0.2 ± 0.2

0.3 ± 0.3

0.3 ± 0.3

0.4 ± 0.3

2

VLF (ms )

2

LF (ms )

2

HF (ms )

2

TP (ms )
Training
Control
2

LF/HF (ms )
Training
Control
2

HF/TP (ms )

Values are mean ± S.D. N = 20 (training group: n = 9; control group: n = 9).

Discussion:
In healthy individuals, an acute bout of IHG elicits an immediate reduction in postexercise ABP and an improvement in vagal HR modulation (30). Unknown was whether:
1) this ABP reduction is sustained (PEH), a finding which would be of great benefit to
individuals with elevated resting ABP (HT), 2) acute post-IHG increases in vagal
modulation also occur in hypertensives, a population with compromised autonomic
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function, and/or 3) these collective responses change with chronic exposure to the IHG
stimulus. The purpose of this investigation was to address the hypotheses that an acute
bout of IHG would cause sustained reductions in ABP (PEH) and improve vagal
modulation of HR in individuals with HT and that 8-weeks of IHG training would attenuate
these post-IHG responses. Three prominent and novel findings emerged from this study:
in medicated hypertensives 1) an acute bout of IHG does not elicit a PEH response, 2)
acute IHG exercise does cause post-exercise improvement in vagal modulation of HR,
and 3) 8-weeks of IHG training does not alter these acute responses.
Acute cardiovascular effects of IHG exercise
Contrary to our hypothesis, an acute bout of IHG exercise did not elicit a PEH
response. Although reductions in SBP (~3 mmHg) have been observed 5-minutes
following IHG exercise in healthy older individuals, this did not translate to sustained
ABP reductions (PEH) in our population of medicated hypertensives (30). In contrast,
SBP and DBP were both elevated above pre-IHG values for the first 5 - 6 hours following
IHG exercise, followed by increases in ABP from 15 - 21 hours post-exercise. We do not
consider this rise to be concerning, however, as all post-IHG values remained within the
normal ambulatory ABP range. The lack of a DBP response to an acute bout of IHG in
this investigation, however, is in line with the findings of Millar and colleagues (30).
Why did we not see a sustained reduction in ABP (PEH) following IHG? The
population in the current study was one of well-controlled medicated hypertensive
individuals (mean resting ABP for the training group: ~114/61 mmHg and for the control
group: ~118/68 mmHg) with well-balanced medication regimens between the two groups
(Table 1), whereas the population in the study by Millar and colleagues (30) had higher
initial ABP (mean resting ABP: 125/74 mmHg). These findings suggest that initial resting
ABP may influence the acute hypotensive response to IHG exercise, just as it does with

75

aerobic exercise. Additionally, many mechanisms have been suggested to play a role in
post-aerobic exercise PEH, one of which is a reduction in cardiac output. Following an
acute bout of aerobic exercise, individuals with HT have sustained reductions in cardiac
output (26), likely due to a reduction in blood volume, leading to a consequent reduction
in stroke volume and ABP (as ABP is the product of cardiac output (stroke volume and
heart rate) and total peripheral resistance (TPR; 20)). Acute resistance exercise also
elicits post-exercise reductions in cardiac output, which again have been attributed to
post-exercise reductions in stroke volume (39). Unlike aerobic and resistance exercises,
IHG exercise may not provide a large enough stimulus or been an effective enough
stimulus in our population of medicated hypertensives to evoke a reduction in blood
volume (sustained or otherwise), leaving stroke volume and cardiac output unaltered and
post-IHG ABP unchanged. Future work should investigate the effects of IHG exercise on
blood volume, stroke volume and cardiac output alterations.
TPR itself is another mechanism thought to be responsible for the PEH response
following aerobic exercise. Reductions in TPR have been observed in hypertensive
individuals following an acute bout of aerobic exercise (27). As aerobic exercise is a
dynamic exercise involving large muscle groups, local vasodilation in the vasculature of
the large muscle masses could account for the ABP reduction post-exercise. IHG
exercise, however, only uses the small muscles of the forearm. The stimulus from IHG
exercise increases vasodilatory capacity and conductance, and lowers resistance in the
forearm vasculature (26); however, these changes may not provide a large enough
alteration, or be sustained for an extended period of time, to evoke systemic changes in
TPR and evoke a PEH response post-IHG. Furthermore, it is generally accepted that
following aerobic exercise there is a marked decrease in sympathetic nerve activity and
an increase in parasympathetic activity (20), and this modulation has been attributed to
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the PEH response (20, 30). The lack of reduction in sympathetic outflow (11), and the
collective lack of alteration in autonomic function following IHG exercise in this study
(discussed below) may also be responsible for the absent PEH response following IHG
exercise in our population of medicated hypertensives.
The elevations as opposed to the anticipated reductions in post-exercise ABP
may have occurred for a number of reasons, including acute anxiety, ambulatory
activities, and early morning rises in ABP. As participants were required to remain in the
laboratory for the first 2 hours post-exercise, ABP may have been influenced by the their
anticipation of leaving the laboratory (33). This was evident by repeat questions of “is it
time to go yet?” or “how much longer.” With respect to the novel measures of postexercise ABP using an ambulatory device, increases in SBP and DBP seen in the first 5
- 6 hours following the IHG exercise were likely due to the ambulatory activity of the
participants. In an attempt to mimic activities of daily living in the general hypertensive
population, activities following laboratory testing were not controlled. For example, many
participants returned to work immediately following the study, which could explain the
observed SBP and DBP increases. The increases in ABP seen from 15 - 21 hours postexercise occurred during the waking times of the participants, 3 am – 9 am, associated
with increases in ABP (13).
Unlike ABP, there was a significant reduction in HR immediately following IHG
exercise (~3 beats/min). This finding is unlike the HR findings of Millar and colleagues
(30), as no significant differences (increase or decrease) in HR following IHG exercise
were observed. Increases in HR, with subsequent increases in cardiac output, have also
been noted following aerobic exercise (20). The variation in HR responses to exercise
may be attributed to the set point of the baroreflex and/or alterations in autonomic
function following isometric exercise. As the participants in the current study experienced
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reductions in HR following exercise, with no alterations in autonomic function (HRV), the
HR reduction is most likely due to acute alterations in baroreflex sensitivity post-exercise
in effort to offset the rise in ABP (20). Alternatively, the reduction in HR observed
following IHG exercise might simply have been due to normal fluctuations in HR that fell
within the range of statistical significance.
Autonomic function was not altered by an acute bout of IHG in our study
population. This finding did not support our hypothesis that vagal modulation of HR
would be improved following a bout of IHG exercise. Again, these findings are in contrast
with the results observed by Millar and colleagues (30), who found marked increases in
parasympathetic activity following IHG exercise. As previously noted, all participants in
the current study were medicated for hypertension, some of whom were on medications
known to increase autonomic function. For example, beta-blockers (BBs) and
angiotensin converting enzyme inhibitors (ACE inhibitors) have been shown to not only
improve ABP, but also improve HRV after 1 month (20,21). As more than half of the
individuals in both our training group and the study population as a whole (Table 1) were
on one or a combination of these drugs, and had been medicated for at least 4 months
before beginning the study, the participants may have reached their capacity for maximal
autonomic improvements. As such, these medications may have contributed to the lack
of a post-IHG alteration in vagal modulation of HR.
Effects of IHG training on the acute cardiovascular responses
To date, there is no documentation of the effects of training on the PEH
response. In the current study, post-exercise increases in ABP remained unaltered with
4- and 8-weeks of IHG training. These findings suggest chronic exposure to the acute
IHG stimulus does not alter the physiological responses to IHG exercise nor does it

78

change the responses to align with our original hypothesis. Again, initial resting ABPs
and medications likely played a role in the lack of change with training. Although
normotensive individuals have shown small PEH responses, these findings are
inconsistent (20). As individuals in this study had ABPs already within the normal range,
the capacity for a PEH response, and therefore a change in this response, was limited.
Remarkably, the acute response to the IHG stimulus was replicated almost identically
after 4- and 8- weeks of training. This supports the theory that the individuals in this
study were much like normotensive individuals, and as such, had a limited ability to alter
their response to the IHG stimulus with training.
After 4-weeks of IHG training, post-IHG HR reductions were similar to those
observed at baseline, however, after 8-weeks of IHG training, this response was no
longer present. It is possible that testing-anxiety or alterations in breathing are
responsible for this change in HR response to the IHG stimulus. Feeling of anxiety
towards the testing session is unlikely, as participants had taken part in testing on prior
occasions, however situational anxiety cannot be ruled out. Contrarily, the lack of a
reduction in HR post-IHG following 8-weeks of training may simply be due to minute-tominute fluctuations in HR.
IHG training did not alter the post-exercise autonomic response to an acute bout
of IHG exercise, and thus did not support our hypothesis of an attenuated increase in
vagal modulation of HR following acute IHG. As with the post-training acute ABP
responses to the IHG stimulus, medications likely played a role in the lack of alterations
in post-exercise HRV following training. As previously mentioned, participants may have
experienced maximum benefits from medication, and therefore, had little to no room for
improvement or changes in indices of HRV.
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Conclusions and Future Direction:
This investigation revealed the novel findings that an acute bout of IHG does not
cause sustained reductions in ABP (PEH) nor does it improve vagal modulation of HR in
a population of well-controlled medicated hypertensives, and these responses are
unchanged with 8-weeks of IHG training. Future studies should investigate the acute and
chronic effects of IHG on post-exercise ABP and HRV in individuals medicated for
hypertension with resting ABP values above the normal range (> 120/80 mmHg), and/or
in unmedicated hypertensives with resting ABP > 140/90 mmHg.
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CHAPTER 4: Effects of isometric handgrip training on resting and 24-hour
ambulatory arterial blood pressure and heart rate variability in individuals
medicated for hypertension
(To be submitted to: Journal of Hypertension)
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Introduction:
Hypertension (HT), a disease characterized by sustained elevations in resting
arterial blood pressure (ABP) and autonomic dysfunction (35), is a prominent risk factor
for the world’s leading cause of death, cardiovascular disease (CVD; 28). It afflicts 1 in 3
Americans (28) and accounts for 77 billion dollars in health care spending in the United
States (17). Aerobic exercise training (walking, running, and cycling, 1 to 7 days/week,
for 30-60 minutes, at 30 to 90% maximum oxygen consumption) significantly reduces
resting systolic ABP (SBP; ~7 mmHg) and diastolic ABP (DBP; ~6 mmHg) in individuals
with HT (30). Resistance exercise training (1 set of 10 repetitions of all the major muscle
groups, 2 - 3 times per week; 1) is recommended as an adjunct to aerobic exercise
training, as the weight of the evidence also supports a reduction in resting ABP (~3
mmHg in both SBP and DBP) (14).
Though resting ABP provides general risk stratification for HT, ambulatory ABP is
more efficacious in predicting CVD related events than clinical resting ABP measures
(31). Aerobic exercise training (walking, running, or cycling, 1 to 7 days/week, for 15-63
minutes, at 30 to 88% heart rate reserve) has been shown to reduce ambulatory ABP
(6). Meta-analyses of aerobic training and ambulatory ABP support reductions in daytime
SBP and DBP of ~3 mmHg and ~2 mmHg, respectively, while nighttime ABP decreased
by ~3 mmHg for both SBP and DBP. Although resistance exercise training and its effect
on 24-hour ambulatory ABP has been investigated to a lesser extent, available evidence
does not support post-training reductions in ambulatory ABP (6).
Isometric handgrip (IHG) training (4, 2-minute bilateral isometric contractions
performed at 30% of maximal voluntary contraction and separated by a timed rest
period, 3X/week for 8 -10 weeks) is a novel and less time consuming form of exercise
training repeatedly shown to reduce resting ABP in small scale investigations in

individuals with and without HT (14,20,21,25). However, the effects of IHG training on
ambulatory ABP are unknown. To date, no randomized controlled trials have examined
the effects of IHG training on resting ABP concomitant with ambulatory ABP.
Spectral analysis of heart rate variability (HRV) is a popular non-invasive tool
used to assess autonomic function, and provides insight into the contributions of the
parasympathetic and sympathetic nervous system (PNS and SNS, respectively) to HR
modulation (35). Coarse graining spectral analysis (CGSA) is a non-invasive frequency
domain analysis method that yields both harmonic and non-harmonic components of the
HRV signal. The harmonic portion of the spectrum is subdivided into very low frequency
(VLF; harmonic noise), low frequency (LF; primarily represents sympathetic neural
oscillations of HR), and high frequency (HF; vagal modulation of HR; 4) components,
with total power (TP) reflecting the complete power of the harmonic spectrum (4).
Although controversial, the ratio of LF: HF is said to provide insight into the
sympathovagal influences contributing to the alterations in HR by the autonomic nervous
system (35). The ratio of HF: TP is indicative of parasympathetic modulation of HR (22).
CGSA allows for more accurate quantitative analysis of HRV by acquiring clearer peaks
in the LF and HF components of the power spectrum (39). This type of analysis is
particularly useful in clinical populations who have reduced harmonic spectral power and
preserved non-harmonic or fractal power, such as those with HT (29).
The effects of aerobic training on heart rate variability (HRV) have been
thoroughly investigated, and although the findings are somewhat inconclusive in young
healthy individuals, the evidence suggests that older individuals and patient populations
(i.e., post-myocardial infarction (post-MI) patients) experience marked improvements in
HRV following aerobic, resistance and IHG training (9,13,18,33,34,35). For example, 8weeks of cycling exercise and calisthenics (1 hour, 5 times per week at 80% HRmax)
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significantly increased parasympathetic modulation of HR (increase HF power) and
decreased sympathetic modulation of HR (decreased LF power) in 22 post-MI individuals
(52 ± 7 years; 21). In 88 older (57 ± 6 years) post-menopausal women, 8- weeks of
running and/or cycling (120 - 165 minutes, 3 - 4 times per week, at 50% VO2max)
significantly increased both sympathetic and parasympathetic modulation of HR
(increased LF and HF power; 13).
The effects of resistance training on HRV have been investigated to a lesser
degree; however, the results continue to support improvements in HRV with training in
clinical populations. In an early study examining the effects of 3 months of resistance
training (whole body circuit training, at a moderate intensity, 3 times per week) in 39
individuals with chronic heart failure (65 ± 11 years; 23), significant increases in
parasympathetic tone and reductions in sympathetic tone were observed following
training (increase in HF power and decrease in LF power). More recently, the effects of
16-weeks of resistance exercise (30 minutes circuit training, 8 - 12 repetitions, 50-80% of
1 repetition maximum, 2 times per week) were examined in 19 women (27 - 60 years
old) with Fibromyalgia who had blunted pre-training HRV (9). Investigators observed
increases in total autonomic modulation of HR (TP) and increased parasympathetic
control of HR (HF power) post-training.
To date, only one study has investigated the effects of IHG training on HRV and
like with the aerobic and resistance training literature, this form of training also appears
to positively influence autonomic modulation of HR. For example, following 10-weeks of
IHG training (4, 30% MVC contractions, sustained for 2-minutes with alternate hands,
separated by a 1-minute rest period, 3x/week), investigators found an increase in resting
vagal tone (increase in HF power) in 17 older (60 - 80 years old) hypertensives (some of
whom were on medication to treat their hypertension; 35).
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Over 29% of people in the United States have HT, yet only 78% of these individuals are
aware of their HT. Importantly, of those who are aware of their HT, only 64% are
successfully treated to target ABP values (≤ 135/85 mmHg and lower) (26). Importantly,
reductions in SBP and DBP of 2 mmHg reduce the risk of stroke by 14% and 17%,
respectively, and the risk of coronary artery disease by 9% and 6%, respectively. As
hypertensive individuals have elevated ABPs and marked reductions in HRV,
improvements in ABP and/or HRV following IHG training may have clinical relevance.
With this knowledge, 3 important, novel research questions emerge: in a randomized
controlled trial of medicated HTs 1) Does IHG training reduce resting ABP? 2) Does IHG
training improve ambulatory ABP? and, 3) Does IHG training improve resting HRV?
Therefore, the purpose of the current randomized controlled study was to address the
hypotheses that IHG training lowers resting and ambulatory ABP and improves resting
HRV in medicated hypertensives.
Methods:
Study Participants. Twenty-five individuals, aged ≥18 years, who had been
receiving pharmacotherapy for HT for at least 4 months, were recruited to participate in
this study. Baseline characteristics of participants are displayed in Table 3. Five
individuals voluntarily withdrew from the study due to time restraints (2 in IHG training
group, 3 in the control group). Individuals with diabetes, a paced heart rhythm at rest,
frequent ventricular premature beats, heart failure, and those who had any physical
limitation that would have prevented them from performing IHG exercise, were excluded
from the study.
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Table 3: Baseline characteristics of participants
Participants

All
(N = 25)

Training Group
(n = 11)

Control Group
(n = 9)

Females (n)

13

4

6

Age (years)

61 ± 8.2

60.0 ± 8.5

62.7 ± 6.1

BMI (kg/m )

30.8 ± 7.2

31.7 ± 7.5

31.0 ± 8.8

Systolic Blood Pressure (SBP; mmHg)

114.6 ± 11.3

113.9 ± 12.7

117.8 ± 14.3

Diastolic Blood Pressure (DBP; mmHg)

67.5 ± 10.3

60.7 ± 11.6

67.5 ± 4.2

Heart Rate (beats/min)

66.9 ± 10.8

62.8 ± 8.5

69.5 ± 15.3

Diuretic

2

2

1

Angiotensin Converting Enzyme (ACE)

3

1

1

Aldosterone Receptor Blocker (ARB)

3

1

1

Calcium Channel Blocker (CCB)

3

2

0

Diuretic + ACE

1

1

0

Diuretic + ARB

3

1

1

ACE + Beta Blocker (BB)

3

1

1

ARB + CCB

1

0

1

ARB + BB

1

1

0

Diuretic + ACE + BB

2

1

1

Diuretic + ARB + BB

1

0

1

Diuretic + ARB + CCB

1

0

0

Diuretic + ARB + CCB + BB

1

1

0

2

Medication: (n)

Values are mean ± S.D

Study design. The University of Windsor Research Ethics Board approved this
randomized controlled investigation, and all participants provided written informed
consent and completed a medical questionnaire. Upon review of the medical
questionnaire and establishment of eligibility, participants underwent familiarization of all
testing procedures. Participants were then randomized to an IHG training group or a
non-exercising control group. In order to blindly randomize participants into groups,
GraphPad software was employed (GraphPad Prism 5, GraphPad Software Inc, La Jolla,

90

CA, USA). Participants assigned to the IHG training group were instructed on proper IHG
exercise techniques.
Following group assignment, all participants underwent baseline-testing
procedures, which were repeated after 4- and 8- weeks of IHG training (or no training for
the control group).
Exercise Training Protocol. Participants assigned to the IHG training group
trained 3 times per week, for a total of 8 weeks. Two training sessions per week took
place under the direct supervision of an exercise trainer, and the third session was
conducted in the participants’ home. Participants were provided with detailed instructions
to ensure proper at home training, and were instructed to record their exercise,
nutritional, and medication data in exercise log books to ensure consistency throughout
the intervention period.
Each training session took approximately 30 minutes. Prior to the on-site training
session, participants had their ABP measured (Dinamap ProCare 100, Critikon, Tampa,
FL, USA); this data was not used for analysis. Participants then performed a bout of IHG
exercise: 4 sets of 2-minute isometric contractions (using alternate hands) were
performed on a programmed handgrip dynamometer (ZonaPLUS, Zona HEALTH, Boise,
ID, USA) at 30% maximal voluntary contraction (MVC; determined at the onset of each
exercise session via electronic linear load cells contained within each IHG device), each
separated by a 1-minute rest interval (20,23).
Participants randomized to the non-exercising control group visited the laboratory 2
times per week to have their ABP measured to ensure equal face-time with investigators
(25).
Testing Protocol. As previously mentioned, all participants underwent testing at
baseline, and after 4- and 8- weeks of IHG training (or no training for the control group).
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To minimize the influence of external factors on the cardiovascular measures,
participants were asked to refrain from the consumption of alcohol and exercise for 24
hours prior to each testing session, and to avoid caffeine consumption for 12 hours prior
(20). All testing was conducted in the morning, in a quiet, temperature-controlled room,
following a light breakfast. On testing days, all participants were asked to void their
bladder prior to the testing session to minimize the effects of bladder distension on blood
pressure (8).
Resting ABP and HR were measured after 10 minutes of seated rest (Dinamap
ProCare 100, Critikon, Tampa, FL, USA; 3). R-R interval HR data was then recorded for
10 minutes for later analysis of resting HRV, using standard electrocardiography (ECG),
whereby a set of 3 electrodes was placed on the participants’ chest (22). To minimize
lead placement errors, the same investigator performed the ECG setup at all testing
sessions (5). After measuring resting ABP, HR and HRV, the participants were fitted with
an ambulatory ABP monitoring device on their right arm, which monitored ABP and HR
for 24-hours (Spacelabs 90207 Ambulatory Blood Pressure Monitor, SpaceLabs Inc.,
Redmond, WA, USA).
Data Analysis:
Resting ABP and HR: Four ABP and HR values were acquired, each separated
by 2 minutes (Dinamap ProCare 100, Critikon, Tampa, FL, USA) by the same trained
investigator following a 10-minute rest period (3). The latter 3 measures were averaged
and used in the final analysis.
Ambulatory ABP and HR: ABPs and HRs were recorded 2 times per hour
during daytime hours (6am - 10pm), and 1 time per hour during nighttime hours (10pm 6am) over a 24-hour period using an ambulatory brachial artery oscillometric device
(Spacelabs 90207 Ambulatory Blood Pressure Monitor, SpaceLabs Inc., Redmond, WA,
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USA) (19). Values were averaged over the entire 24-hour ambulatory period (mean 24hr), and during each time period (daytime and nighttime).
Resting HRV analysis: Beat-to-beat HR was acquired using standard
electrocardiography (ECG), as previously described (22). HR signal output was sampled
at a frequency of 1,000 Hz. The analogue signals were converted to digital signals using
a data acquisition board (PowerLab 8/30, ADInstruments Inc., Colorado Springs, CO,
USA) for off-line beat-to-beat analysis. Ensemble averages of 256 beat sequences were
taken from a minimum time series of 400 beats (22). Ectopic beats were edited and
replaced via linear interpolation from adjacent cardiac cycles (22). Only tracings with
≤5% ectopy-corrected beats were accepted for analysis (22), thus 2 of the 20
participants were excluded from the HRV analysis (both of whom were in the training
group). To assess HRV, these R-R (i.e. pulse) intervals were then submitted to CGSA
(22,39).
Statistical Analysis:
One-way ANOVAs (group) of baseline resting ABP, 24-hour ambulatory ABP and
HRV were employed to determine if baseline differences existed between the training
and control groups. As no differences were revealed (P ≥ 0.05), two-way ANOVAs
(group x time) were used to analyze resting ABP (SBP, DBP) and HR, 24-hour
ambulatory ABP (24-hour mean ABP, nighttime ABP, and daytime ABP) and resting
HRV (VLF, LF, HF, TP, LF: HF ratio, HF: TP ratio). Where applicable, post-hoc analyses
were conducted using paired-sample t-tests, which used Bonferroni corrected alpha
levels.
All data were re-assessed after separately controlling for, as between subject
factors, gender (male or female), medication (single or multiple medications) and
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baseline ABP (controlled to within the normal range (≤120/80 mmHg) or uncontrolled
(≥120/80 mmHg)).
The training group was further divided into IHG training responders, who experienced
clinically significant reductions in ABP (≥ 2 mmHg; 30), and non-responders (those who
did not achieve reductions in ABP ≥ 2 mmHg). One-way ANOVA (group) was employed
to determine if baseline differences existed between groups for baseline ABP, age, and
BMI. As no differences were observed (P ≥ 0.05), two-way ANOVAs (group x time) were
employed to analyze resting ABP (SBP, DBP) and HR. We did not re-categorize our
population into responders and non-responders for ambulatory ABP, as we were
unaware of any existing literature specifying clinically relevant reductions in ambulatory
ABP related to reduced CVD risk.
Statistical significance was set at P ≤ 0.05. Results are mean ± S.D., unless
otherwise specified. Analysis of data was completed using IBM (PASW) SPSS Statistics
18 (SPSS Inc., Chicago, IL, USA).
Results:
Effects of IHG training on resting ABP and HR
Following 4- and 8- weeks of IHG training (or no training for the control group), no
significant changes in resting SBP, DBP, or HR were observed in either the training
group or in the control group (all P ≥ 0.05). Results are shown in Table 4.
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Table 4: Resting SBP and DBP at baseline, after 4- and 8-weeks of training.
Baseline

After 4-weeks of
training

After 8-weeks of
training

Control Group

113.3 ± 11.8

111.4 ± 14.4

118.4 ± 15.5

Training Group

112.2 ± 11.0

110.9 ± 7.1

111.3 ±7.7

Control Group

61.9 ± 12.4

60.6 ± 10.5

63.5 ± 12.4

Training Group

68.9 ± 7.0

66.9 ± 8.7

69.0 ± 7.4

Control Group

62.9 ± 8.6

59.9 ± 7.7

61.3 ± 9.0

Training Group

66.1 ± 12.0

65.6 ± 13.7

67.9 ± 14.7

SBP (mmHg)

DBP (mmHg)

HR (beats/min)

Values are mean ± S.D; all P > 0.05. N = 20 (training group: n = 11; control group: n = 9).

When participants in the training group were divided into responders and nonresponders, 6 of the 11 participants experienced clinically relevant reductions in SBP
(~9.0 ± 5.2 mmHg), while 5 of the 11 showed clinically relevant DBP reductions (~2.0 ±
1.6 mmHg). Two-way analysis of variance of SBP revealed a significant interaction
between time and group (P = 0.001). Post-hoc analyses showed a significant reduction
in SBP (P = 0.008) from baseline to 8-weeks in the responder group, and no significant
reductions in SBP (P = 0.07) in the non-responder group. No significant interactions or
main effects were revealed for DBP or HR, for either group (P > 0.05) at any time point.
The baseline characteristics of responders and non-responders, with respect to SBP, are
shown in Table 5.
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Table 5: IHG training responder versus non-responder baseline characteristics
N = 11

Responders
(n = 6)

Non-responders
(n = 5)

Females

3

1

59.0 ± 7.6

58.8 ± 9.5

35.7 ± 9.8

28.6 ± 2.9

SBP

115.2 ± 8.9

108.5 ± 12.7

DBP

67.6 ± 5.3

70.5 ± 8.9

68.3 ± 8.4

63.4 ± 15.9

Diuretic

1

1

ACE

0

1

ARB

1

0

CCB

1

1

Diuretic + ACE

1

0

ACE + BB

0

1

ARB + BB

1

0

Diuretic + ACE + BB

0

1

Diuretic + ARB + CCB + BB

1

0

Age (years)
2

BMI (kg/m )
Resting ABP (mmHg)

HR (beats/min)
Medication: (n)

Values are mean ± S.D.; all P > 0.05.

Effects of IHG training on 24-hour ambulatory ABP
Small reductions in 24-hour mean SBP, DBP and HR for the training group were
noted, however, these findings were not statistically significant when compared to the
non-exercising control group (all P > 0.05) at any time point. For 24-hour mean SBP,
there was a trend towards a group and time interaction (P = 0.07) over the 8 week
period. Nighttime SBP, DBP and HR did not significantly change from baseline (all P >
0.05) for either group with 4- or 8- weeks of IHG training, yet, again, there was a trend
towards a group x time interaction for a reduction in nighttime SBP (P = 0.06) over the
entire training period (8-weeks). For both groups, daytime SBP, DBP, and HR remained
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unchanged after 4- and 8-weeks of IHG training (all P > 0.05). All ambulatory ABP
results are shown in Table 6.
Table 6: 24-hour mean SBP and DBP at baseline, after 4- and 8-weeks of training.
Baseline

After 4-weeks of
training

After 8- weeks of
training

Control Group

126.2 ± 10.4

130.4 ± 8.5

127.9 ± 9.5

Training Group

127.4 ± 10.1

125.6 ± 8.9

125.5 ± 8.6

Control Group

71.4 ± 7.8

74.2 ± 8.4

71.7 ± 7.14

Training Group

76 ± 6.0

75.6 ± 6.0

74.4 ± 6.0

Control Group

62.8 ± 10.1

63.0 ± 8.5

62.2 ± 10.4

Training Group

68.3 ± 9.5

67.1 ± 9.7

67.6 ± 10.3

Control Group

130.6 ± 11.5

134.0 ± 10.6

133.1 ± 10.9

Training Group

132.0 ± 8.8

130.5 ± 7.6

131.1 ± 8.9

Control Group

75.1 ± 8.9

76.3 ± 9.5

75.2 ± 8.0

Training Group

80.0 ± 6.2

79.6 ± 6.8

79.5 ± 7.3

Control Group

66.2 ± 10.8

65.8 ± 9.3

64.4 ± 10.4

Training Group

71.3 ± 10.7

69.6 ± 11.1

71.0 ± 10.5

Control Group

117.9 ± 8.7

123.4 ± 7.7

119.0 ± 7.9

Training Group

120.0 ± 13.9

116.6 ± 12.5

116.0 ± 8.5

Control Group

65.1 ± 6.5

69.9 ± 6.9

64.7 ± 6.6

Training Group

69.2 ± 7.3

67.8 ± 6.1

65.6 ± 5.6

Control Group

56.6 ± 9.3

57.4 ± 8.2

58.4 ± 10.5

Training Group

63.4 ± 9.6

62.5 ± 10.0

61.8 ± 9.6

Variables
24-hour mean SBP (mmHg)

24-hour mean DBP (mmHg)

24-hour mean HR (beats/min)

Daytime SBP (mmHg)

Daytime DBP (mmHg)

Daytime HR (beats/min)

Nighttime SBP (mmHg)

Nighttime DBP (mmHg)

Nighttime HR (beats/min)

Values are mean ± S.D.; all P > 0.05. N = 20 (training group: n = 11; control group: n = 9).
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Effects of IHG training resting HRV
Following 4- and 8-weeks of IHG training, no significant differences were
observed, in any indices of HRV (VLF, LF, HF, TP, LF: HF ratio and HF: TP ratio; all P >
0.05). All data are presented in Table 7.

Table 7: Resting HRV indices at baseline, after 4- and 8- weeks of training.
Baseline

After 4-weeks of
training

After 8-weeks of
training

Training

203.7 ± 275.0

99.2 ± 86.0

113.0 ± 132.0

Control

158.0 ± 122.7

99.4 ± 86.2

98.6 ± 107.7

Training

86.9 ± 144.1

50.7 ± 33.6

47.7 ± 48.3

Control

108.2 ± 120.6

76.2 ± 64.3

47.7 ± 61.3

Training

65.0 ± 103.6

102.7 ± 119.6

83.8 ± 109.1

Control

93.0 ± 124.0

41.5 ± 33.2

73.1 ± 91.5

355.6 ± 486.7

252.7 ± 211.8

244.4 ± 252.6

359.2 ± 323.7

217.1 ± 124.1

219.4 ± 172.9

2.1 ± 2.1

0.8 ± 0.8

3.2 ± 5.6

3.1 ± 6.1

3.8 ± 4.9

1.6 ± 2.5

Training

0.3 ± 0.2

0.4 ± 0.2

0.4 ± 0.3

Control

0.2 ± 0.1

0.2 ± 0.2

0.3 ± 0.3

2

VLF (ms )

2

LF (ms )

2

HF (ms )

2

TP (ms )
Training
Control
2

LF/HF (ms )
Training
Control
2

HF/TP (ms )

Values are mean ± S.D.; all P > 0.05. N = 18 (training group: n = 9; control group n = 9).

Discussion:
Numerous small-scale studies in individuals with and without HT have
investigated the effects of IHG training induced reductions in ABP, yet no randomized
control trial to date has investigated its effects targeting solely medicated hypertensives.
As 68% of individuals diagnosed with HT are receiving pharmacotherapy to treat their
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HT, research focusing on this population is warranted. Secondly, no studies have
investigated the effects of IHG training on ambulatory ABP, a clinically significant
measure that provides a more comprehensive understanding of CVD risk (7).
Furthermore, only one study has investigated the effects of IHG training on HRV, an
important predictor of CVD related mortality (3,10,16,32), yet, many of the individuals in
this study were not on medication for HT. Therefore, this study aimed to answer the
novel questions: in medicated hypertensives 1) Does IHG training reduce resting ABP?
2) Does IHG training improve ambulatory ABP? and, 3) Does IHG training improve
resting HRV?
Effects of IHG training on resting ABP and HR
Though the current study found small resting SBP reductions (~1 mmHg) for the
training group, these findings did not reach statistical significance. The lack of SBP
change was contrary to our hypothesis, and to the weight of published IHG studies in
hypertensive individuals (25,35). Although reductions in resting DBP were not observed,
these findings are in line with some of the current IHG literature. For example, Taylor and
colleagues (35) reported significant reductions in resting SBP (~19 mmHg), but no
significant reductions in DBP in older individuals with HT (mean resting ABP: ~156/82
mmHg; many of whom were unmedicated) following 10-weeks of IHG training (35). In
accordance with findings from Taylor and colleagues, McGowan and colleagues, using a
with-in subject study design, investigated the effects of IHG training on a group of
medicated hypertensives (mean resting ABP: ~134/73 mmHg) and found reductions in
SBP (~15 mmHg) and no significant reductions in DBP. Although numerous IHG studies
in normotensive individuals cite post-training reductions in DBP (20,37), the discrepancy
in DBP finding between the current study and the normotensive studies may likely be
due to protocol differences, suggesting the IHG training stimulus over 8-weeks may not
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be sufficient to alter DBP in hypertensives. Alternatively, as a multilevel analysis
performed to amalgamate previous IHG training studies performed in individuals with
hypertension (25) showed a combined post-training DBP reduction of ~3 mmHg, it is
possible that greater numbers of participants are required to detect a statistically
significant reduction in DBP.
Why did we not replicate previously observed reductions in resting SBP in our
population of medicated hypertensives? The lack of a reduction in SBP may be attributed
to: 1) initial resting ABP, 2) IHG protocol, and/or 3) changes in physical activity and/or
nutrition over the course of the study. As our study involved well-controlled medicated
hypertensives (115/68 mmHg), the capacity for these individuals to respond to the IHG
training stimulus may have been limited. Other studies that investigated the effects of
IHG training in individuals with HT employed populations with higher initial ABPs, and as
such, had a larger capacity for improvement (23,35). In support of this, a recent
multilevel-analysis revealed that initial ABP had a significant effect on an individual’s
ABP response to IHG training, with individuals with higher ABPs showing larger
reductions in resting ABP (25). Protocol differences may have also played a role in the
lack of an observed reduction in SBP. Hypertensive individuals who are receiving
pharmacotherapy may require a larger (greater % MVC) and/or longer (timed
contraction, number of contractions and/or length of training) IHG stimulus. Finally,
physical activity and/or nutritional changes may have contributed to the lack of SBP
reductions in this study however, we consider this unlikely as both were monitored
throughout the investigation.
As only 75% of individuals with HT experienced resting ABP reductions following
exercise prescription (aerobic exercise training for 8 - 78 weeks, 2 - 6 times per week, at
50 - 80% VO2max; 12), the training group was subdivided into individuals who responded
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to IHG training (those that experience clinically significant IHG induced resting SBP
reductions of ≥ 2 mmHg; 30) and those who did not respond (< 2 mmHg reduction in
resting SBP). Although not statistically different, the responder group had higher baseline
resting SBP (~6 mmHg) than those in the non-responding group. Again, this finding is in
line with the weight of the evidence that suggests those with higher ABP experience the
greatest hypotensive benefits from IHG training. There was also a marked difference,
although not statistically significant, between the BMIs of the two groups. The responder
group had a higher BMI (~36 kg/m2) than did the non-responder group (~29 kg/m2). BMI
is associated with a persons’ state of health, and as such, may have also played a role in
their capacity to respond to an exercise intervention, as those in this study with higher
BMIs experienced the greatest improvements in ABP following IHG training (24).
Ambulatory ABP
This is the first study to investigate the effects of IHG training on ambulatory ABP.
In the current study, no statistically significant improvements were observed for any
component of ambulatory ABP (mean 24-hr, daytime, or nighttime), a finding of which
was in contrast to our hypothesis. Though not statistically significant (although a trend
was noted), clinically relevant reductions in mean 24-hr SBP (~3 mmHg) (30) were
observed following IHG training. Higher ambulatory ABPs increase one’s risk of CVD (7),
and as such, the reductions in mean 24-hour SBP in the current study may have the
potential of reducing CVD risk (30). This reduction is in line with 24-hour mean
ambulatory SBP reductions seen following aerobic exercise training (40 minutes of
cycling, 3 times per week, for 10 weeks), though, like with IHG training, these reductions
also did not achieve statistical significance (27).
For nighttime ambulatory SBP, the training group experienced post-training
reductions that approached statistical significance, and thus the small size of the study
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may have contributed to this finding. Alternatively, ambulatory activities were not
controlled during the testing days at baseline, and after 4- and 8- weeks of training (or no
training for the control group), and may have minimized the potential to observe
significant changes, however, we consider this unlikely, as participants reported no
changes in daily physical activities throughout the course of the investigation.
Resting HRV
This investigation showed no significant improvement in any indices of HRV with
IHG training. These finding are in contrast to our hypothesis that individuals would
experience an improvement in HRV with IHG training, and contradict the findings of
Taylor and colleagues (35), who noted marked improvements in vagal modulation of HR,
in hypertensives, following 10-weeks of IHG training. An important distinction between
the current study and the previously discussed study is that although both populations
involved individuals with HT, in our study, all of our population was receiving
pharmacotherapy for their HT. Autonomic function is known to improve with the
prescription of ACE inhibitors and BBs (15,18), as these medications affect the
autonomic nervous system. As participants in the study by Taylor and colleagues (35)
were not all on HT medications, as a group they may have had a greater capacity to
experience IHG training induced improvements in autonomic function. Furthermore,
these individuals had hypertensive resting ABPs (> 150/80 mmHg), which suggests less
effective control of resting ABP with pharmacotherapy, thus permitting a greater ABP
and autonomic change with IHG training. As most of the individuals in this study were on
an ACE inhibitor or BB, or a combination of an ACE inhibitor and a BB, they may have
experienced maximum autonomic improvements from the pharmacotherapy and thus
were unable to respond and/or had a blunted response to IHG training.
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Conclusions and Future Directions:
These findings suggest individuals who are treated to within the normal ABP
range (≤ 120/80 mmHg) may not experience ABP and HRV benefits from IHG training.
Future studies should concentrate on populations of medicated and/or unmedicated
hypertensives with ABPs above the normal range. Large scale trials aimed at these
populations are necessary as they may reveal significant alterations in ABP, particularly
ambulatory ABP, as our data suggests clinically relevant post-training improvements in
ambulatory SBP (mean 24-hour and nighttime). This finding provides vital information
regarding the limitations of assessing resting ABP alone, as the current study found no
reductions in resting ABP. As ambulatory ABP is a better predictor of morbidity and
mortality than resting ABP (7), it is important that future studies measure ambulatory
ABP in addition to resting ABP.
Furthermore, the ability to classify individuals as responders or non-responders would
provide effective and timely treatment regimes for HT individuals. Currently, only one
study has investigated the predictability of IHG training success using cardiovascular
reactivity tasks in normotensive individuals (26). Such studies should be conducted in
hypertensives to establish whether this is an efficacious way of predicting IHG training
hypotensive responses. Future studies should also aim to further stratify medication
regimens to help provide a broader understanding of the effects of medication, alone or
in combination, on the ABP and HRV responses to IHG exercise.
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CHAPTER 5: General Discussion
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CVD is the leading cause of death in Canada, with HT significantly contributing
to the risk of its development. HT is a complex pathophysiological disease, which rarely
can be attributed to a known cause. Individuals with HT have elevated resting and
ambulatory ABP experience PEH following many forms of exercise, and have reduced
HRV.
The prevention and treatment of HT include lifestyle modifications and
pharmacotherapy. Many individuals treated with pharmacotherapy are treated to within
the normal ABP range, yet others remain unaffected (7). Lifestyle modifications,
particularly exercise, have proven to be a successful means of lowering resting and
ambulatory ABP (4,5,8) and improving HRV (1,2,3).
IHG training is a novel, less time consuming, simple exercise, shown, in
individuals with and without HT, to markedly reduce resting ABP (6). The transfer of
these effects to activities of daily living (i.e., ambulatory ABP), however, is currently
unknown. Furthermore, individuals with HT have shown improvements in HRV with IHG
training (8); however, the PEH and HRV responses post-IHG in HT individuals remain
unknown, as are the effects of training on these responses.
The overall aim of this thesis was to answer the following research questions:
1) Does a bout of IHG elicit a PEH response and improvements in vagal modulation of
HR in individuals medicated for HT, and do these responses change with 8-weeks of
IHG training? and, 2) Does IHG training reduce resting ABP and 24-hour ambulatory
ABP and improve vagal modulation of HR in medicated hypertensive?
Research Question 1: Does a bout of IHG elicit a PEH response and improve
vagal modulation of HR in individuals medicated for HT, and do these responses change
with 8-weeks of IHG training?
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Our investigation found that a bout of IHG did not elicit a PEH response nor did it
improve vagal modulation of HR. Following 4- and 8-weeks of training, the observed
ABP and HRV responses were unchanged, and remarkably, they remained similar to the
ABP and HRV responses observed at baseline, demonstrating a sustained response to
IHG exercise.
Research Question 2: Does IHG training reduce resting and 24-hour ambulatory
ABP and improve vagal modulation of HR in medicated hypertensive?
This investigation found no resting ABP or ambulatory ABP reductions following 4or 8-weeks of IHG training, and all indices of HRV, including vagal HR modulation, were
also unaltered with IHG training.
The population in this study was one of well-controlled medicated hypertensive
individuals with ABPs within the normal range. These individuals may have experienced
the maximum improvements in ABP and HRV with their HT medications, which may
have limited their acute post-IHG responses, as well as their IHG training responses.
The IHG exercise stimulus may not have been great enough to elicit a PEH
response or alterations in HRV following acute IHG exercise, or following IHG training in
well-controlled medicated hypertensives. For this population, a greater stimulus (> 30%
MVC), a longer duration of the sustained contractions (> 2-minutes) or their frequency (>
4 contractions), and/or a longer intervention period (> 8 weeks) may be needed to elicit
the anticipated responses.
The results of this study should be interpreted with caution, as many individuals
in the general population with HT are not controlled to within the ABP normal ranges.
The participants in this study were among the 64% of those who are effectively
controlled with medication for their HT, and as such, do not provide an accurate
representation of the general hypertensive population.
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In summary, the primary findings of this investigation are: 1) IHG exercise does not
elicit an acute PEH response nor does it alter post-IHG HRV in well-controlled medicated
hypertensives, and these responses are unchanged with IHG training, and, 2) IHG
training does not significantly reduce resting or ambulatory ABP, nor does it improve
indices of HRV at rest in this population.
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Appendix A

Individuals on Medication for HIGH BLOOD PRESSURE are
invited to participate in a Research Study
Dr. McGowan and Cassandra Stiller-Moldovan at the University of Windsor are currently
looking for individuals to participate in a study, approved by the Research Ethics Board,
examining the effects of handgrip exercise on individuals medicated for high blood
pressure.
We invite people who:
• Have high blood pressure
• Are on medication for high blood pressure
If you are interested and would like more information please contact:
Cassandra Stiller-Moldovan: (519)-253-3000 ext. 4979
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Appendix B
Radio Advertisement:
Attention individuals with high blood pressure. If you are currently on medication for high
blood pressure you may be eligible to participate in a research study at the University of
Windsor conducted by Dr. McGowan and Cassandra Stiller-Moldovan. For more
information please contact: Cassandra Stiller-Moldovan at 519-253-3000, ext 4979.
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Appendix E

LETTER OF INFORMATION FOR CONSENT TO PARTICIPATE IN RESEARCH
Title of Study: The effects of isometric handgrip exercise on post-exercise hypotension and heart rate
variability in individuals medicated for hypertension.
You are asked to participate in a research study conducted by Ms. Cassandra Stiller-Moldovan and Dr.
Cheri McGowan, from the Department of Kinesiology at the University of Windsor. Ms. Cassandra StillerMoldovan will be using this study to conduct research for her pursuit of a master’s degree in Human
Kinetics.
If you have any questions or concerns about the research, please feel to contact Dr. Cheri McGowan
(faculty supervisor) at 519-253-3000 ext. 2451 or via email at mcgowanc@uwindsor.ca
PURPOSE OF THE STUDY
The main purpose of this study is to examine the blood pressure response immediately after a bout of
isometric handgrip exercise in people who are taking medication to control their high blood pressure. We are
also interested in seeing if this changes after 8 weeks of using the handgrip 3X per week. We also expect
isometric handgrip training to lower your resting blood pressure, and to improve how your heart varies its
rhythm.
PROCEDURES
If you volunteer to participate in this study, we would ask you to do the following things:
Eligibility/Consent/Familiarization Procedures
Visit 1:
After expressing interest in the study, if you meet the inclusion criteria, you will be invited to meet the
investigators at the Applied Human Performance Laboratory (Department of Kinesiology, University of
Windsor). At that time, you will be asked to read the consent form and information sheet on the study. After
meeting with Ms. Cassandra Stiller-Moldovan and Dr. Cheri McGowan (study investigators), you will be
familiarized with all portions of the investigation. If you are still interested in participating in the study, you will
be asked to sign the consent form. Once you have given consent, you will fill out a brief medical
questionnaire. At this time, we encourage you to ask any questions you have.
Visit 2:
To familiarize you with the procedures involved, you will undergo practice testing of resting blood pressure
and heart rate acquisition. After this information has been collected, you will be randomized into one of two
groups: 1) isometric handgrip training group, or 2) the control group (non-exercising). If you are randomized
to the isometric handgrip training group, you will be shown how to properly perform a bout of isometric
handgrip exercise. You will continue this exercise program for 8 weeks. If you are randomized to the control
group, you will not exercise during the 8 week training period.
rd

Measurement Procedures- 3 visit to completion of investigation:
If you are randomized to the isometric handgrip group or the control group, you will undergo the same
testing procedures. Testing will take place over 2 days before you start the study, in the Applied Human
Performance Laboratory (Department of Kinesiology, University of Windsor). These procedures will be
repeated in all participants after 4 week and 8 week of training. All measurements will take place in the
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morning in a quiet, temperature-controlled room after a light, standardized breakfast (e.g., you will eat the
same breakfast before each testing session), and you will take your medication at the same time. To
minimize the influence of outside factors on these measures, you will be asked to avoid drinking alcohol and
exercising for 24 hours before each testing session, as well as avoiding caffeine for 12-hours before the
testing session. Your blood pressure medication will be monitored throughout the study, including your
dosage, and the time of day you take the medication. Should your blood pressure medication change (dose,
addition or removal of a medication) during the study, you must let one of the investigators know, and your
results will be removed from the study. However, you may stay in the study until it is complete.
Day 1 (approximately 1 hour): After 10 minutes of seated rest, your resting blood pressure will be measured.
We will take your blood pressure using a method that is similar to the way your doctor takes your blood
pressure in their office. You will then participate in two tasks. The first will involve you placing your hand in
cold water for 2 minutes. After this task, you will rest for 10 minutes in a seated position. Next, you will
perform the second task, which involves mental arithmetic. You will be asked to subtract a 2-digit number
from a number presented to you and say your answer aloud. You will be shown a total of 25 numbers, and
will be given 5 seconds to complete each number. Following these tests, you will be sent home with a blood
pressure device that will monitor your blood pressure for the next 24-hours. You will return the device the
following morning.
Day 2 (approximately 3.5 hours): After 10 minutes of seated rest, your resting blood pressure will be
measured, in the same way as it was on Day 1. Heart rate will be measured using standard
electrocardiography, whereby a set of 3 electrodes will be placed on your chest. Heart rate will be recorded
for 10 minutes. Following this data collection period, you will perform a bout of isometric handgrip exercise:
you will perform 4 sets of 2-minute hand squeezing exercises (using alternate hands) on a programmed
handgrip device at 30% of your maximum squeezing ability (which will be determined at the beginning of
each exercise session with the handgrip device), separated by 1-minute rest intervals. During this exercise
protocol, your heart rate will be recorded. Immediately following the last rest period, we will record your
heart rate for 10 minutes. Following an additional 5-minute rest period, your blood pressure will be recorded.
Your blood pressure will again be evaluated after 1 hour and 2 hours following the exercise session.
Following the final blood pressure evaluation, we will send you home will a device that will record your blood
pressure for the next 24 hours. The morning following the Day 2 testing session, you will return this device.
If you are randomized to the handgrip exercise group, you will train 3 times per week, for a total of 8 weeks.
Two training sessions per week will take place under the supervision of an exercise trainer, where your
resting blood pressure will be acquired, before each session, and the third session will be conducted in the
your home. You will be provided with detailed instructions to ensure proper at home training, and will be
instructed to record your exercise, nutritional, and medication data in exercise log books we will provide for
you. If you are randomized to the control group, you will visit the laboratory 2 times per week for resting
blood pressure measurements, for a total of 8 weeks.
Everyone will undergo identical testing procedures, which will occur on week 5, and week 9 of the study.
As mentioned above, you will be assigned to a handgrip exercise or a control group through random
assignment. Testing visits will range between 30 minutes and 3.5 hours. For those randomized to the
handgrip training group, training sessions will last no more than 30 minutes.
Visits to the University of Windsor for testing will take place during week 1, week 5, and week 9 of this
study. You will be given a schedule of events for the study, to ensure your understanding and availability.
You will be notified via email and/or phone call for follow-up sessions.
POTENTIAL RISKS AND DISCOMFORTS
If you are assigned to the handgrip training group, you may experience tendonitis in the trained tendons,
however this risk is minimal if the exercise is properly performed. The blood pressure measurement
procedure is non-invasive, as is electrocardiography for acquiring heart rate. However, in rare instances, you
may experience numbness and/or tingling in the occluded limb while we are measuring your blood pressure
and/or a minor rash from the heart electrode stickers we use to measure your heart rate.
POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY
You may or may NOT experience a lower resting blood pressure by participating in this study.
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PAYMENT FOR PARTICIPATION
Subjects will not receive payment for participation in this study.
CONFIDENTIALITY
Any information that is obtained in connection with this study and that can be identified with you will remain
confidential and will be disclosed only with your permission.
To ensure anonymity of subjects, following consent, all participants will be assigned an identification
number. To ensure confidentiality, no mention of subject names will be used in any publication or
presentation, and participants will be identified only by their identification number on all collection tools
(electronic or otherwise). All paper data will be stored in a locked filing cabinet in the locked office of the
principal investigators (HK 133, Department of Kinesiology, University of Windsor), and all electronic data
will be stored in a locked laboratory (Applied Human Performance Laboratory, Department of Kinesiology,
University of Windsor). Information stored on computer will be password-accessible only, and will be
available only to the study investigators. With respect to final disposal, all paper records (including medical
questionnaires) will be shredded.
PARTICIPATION AND WITHDRAWAL
You can choose whether to be in this study or not. If you volunteer to be in this study, you may withdraw at
any time without consequences of any kind. You may also refuse to answer any questions you don’t want to
answer and still remain in the study. The investigator may withdraw you from this research if circumstances
arise which warrant doing so.
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS
Subjects will have the option of receiving results from the study either by mail or email. Results will also be
posted on the REB website in April 2010.
Web address: http://www.uwindsor.ca/reb
Date when results are available: April 2010
SUBSEQUENT USE OF DATA
This data may be used in subsequent studies. As data will be collected under the subject’s identification
number, data used for ongoing studies will ensure the privacy of the subjects.
RIGHTS OF RESEARCH SUBJECTS
You may withdraw your consent at any time and discontinue participation without penalty. If you have
questions regarding your rights as a research subject, contact: Research Ethics Coordinator, University of
Windsor, Windsor, Ontario N9B 3P4; Telephone: 519-253-3000, ext. 3948; e-mail: ethics@uwindsor.ca
SIGNATURE OF INVESTIGATOR
These are the terms under which I will conduct research.
_____________________________________
Signature of Investigator

____________________
Date

Revised February 2008
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Appendix F

CONSENT TO PARTICIPATE IN RESEARCH
Title of Study: The effects of isometric handgrip exercise on post-exercise hypotension and heart rate
variability in individuals medicated for hypertension.
You are asked to participate in a research study conducted by Ms. Cassandra Stiller-Moldovan and Dr.
Cheri McGowan, from the Department of Kinesiology at the University of Windsor. Ms. Cassandra StillerMoldovan will be using this study to conduct research for her pursuit of a master’s degree in Human
Kinetics.
If you have any questions or concerns about the research, please feel to contact Dr. Cheri McGowan
(faculty supervisor) at 519-253-3000 ext. 2451 or via email at mcgowanc@uwindsor.ca
PURPOSE OF THE STUDY
The main purpose of this study is to examine the blood pressure response immediately after a bout of
isometric handgrip exercise in people who are taking medication to control their high blood pressure. We are
also interested in seeing if this changes after 8 weeks of using the handgrip 3X per week. We also expect
isometric handgrip training to lower your resting blood pressure, and to improve how your heart varies its
rhythm.
PROCEDURES
If you volunteer to participate in this study, we would ask you to do the following things:
Eligibility/Consent/Familiarization Procedures
Visit 1:
After expressing interest in the study, if you meet the inclusion criteria, you will be invited to meet the
investigators at the Applied Human Performance Laboratory (Department of Kinesiology, University of
Windsor). At that time, you will be asked to read the consent form and information sheet on the study. After
meeting with Ms. Cassandra Stiller-Moldovan and Dr. Cheri McGowan (study investigators), you will be
familiarized with all portions of the investigation. If you are still interested in participating in the study, you will
be asked to sign the consent form. Once you have given consent, you will fill out a brief medical
questionnaire. At this time, we encourage you to ask any questions you have.
Visit 2:
To familiarize you with the procedures involved, you will undergo practice testing of resting blood pressure
and heart rate acquisition. After this information has been collected, you will be randomized into one of two
groups: 1) isometric handgrip training group, or 2) the control group (non-exercising). If you are randomized
to the isometric handgrip training group, you will be shown how to properly perform a bout of isometric
handgrip exercise. You will continue this exercise program for 8 weeks. If you are randomized to the control
group, you will not exercise during the 8 week training period.
rd

Measurement Procedures- 3 visit to completion of investigation:
If you are randomized to the isometric handgrip group or the control group, you will undergo the same
testing procedures. Testing will take place over 2 days before you start the study, in the Applied Human
Performance Laboratory (Department of Kinesiology, University of Windsor). These procedures will be
repeated in all participants after 4 week and 8 week of training. All measurements will take place in the
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morning in a quiet, temperature-controlled room after a light, standardized breakfast (e.g., you will eat the
same breakfast before each testing session), and you will take your medication at the same time. To
minimize the influence of outside factors on these measures, you will be asked to avoid drinking alcohol and
exercising for 24 hours before each testing session, as well as avoiding caffeine for 12-hours before the
testing session. Your blood pressure medication will be monitored throughout the study, including your
dosage, and the time of day you take the medication. Should your blood pressure medication change (dose,
addition or removal of a medication) during the study, you must let one of the investigators know, and your
results will be removed from the study. However, you may stay in the study until it is complete.
Day 1 (approximately 1 hour): After 10 minutes of seated rest, your resting blood pressure will be measured.
We will take your blood pressure using a method that is similar to the way your doctor takes your blood
pressure in their office. You will then participate in two tasks. The first will involve you placing your hand in
cold water for 2 minutes. After this task, you will rest for 10 minutes in a seated position. Next, you will
perform the second task, which involves mental arithmetic. You will be asked to subtract a 2-digit number
from a number presented to you and say your answer aloud. You will be shown a total of 25 numbers, and
will be given 5 seconds to complete each number. Following these tests, you will be sent home with a blood
pressure device that will monitor your blood pressure for the next 24-hours. You will return the device the
following morning.
Day 2 (approximately 3.5 hours): After 10 minutes of seated rest, your resting blood pressure will be
measured, in the same way as it was on Day 1. Heart rate will be measured using standard
electrocardiography, whereby a set of 3 electrodes will be placed on your chest. Heart rate will be recorded
for 10 minutes. Following this data collection period, you will perform a bout of isometric handgrip exercise:
you will perform 4 sets of 2-minute hand squeezing exercises (using alternate hands) on a programmed
handgrip device at 30% of your maximum squeezing ability (which will be determined at the beginning of
each exercise session with the handgrip device), separated by 1-minute rest intervals. Immediately following
the last rest period, we will record your heart rate for 10 minutes. Following an additional 5-minute rest
period, your blood pressure will be recorded. Your blood pressure will again be evaluated after 1 hour and 2
hours following the exercise session. Following the final blood pressure evaluation, we will send you home
will a device that will record your blood pressure for the next 24 hours. The morning following the Day 2
testing session, you will return this device.
If you are randomized to the handgrip exercise group, you will train 3 times per week, for a total of 8 weeks.
Two training sessions per week will take place under the supervision of an exercise trainer, where your
resting blood pressure will be acquired, before each session, and the third session will be conducted in the
your home. You will be provided with detailed instructions to ensure proper at home training, and will be
instructed to record your exercise, nutritional, and medication data in exercise log books we will provide for
you. If you are randomized to the control group, you will visit the laboratory 2 times per week for resting
blood pressure measurements, for a total of 8 weeks.
Everyone will undergo identical testing procedures, which will occur on week 5, and week 9 of the study.
As mentioned above, you will be assigned to a handgrip exercise or a control group through random
assignment. Testing visits will range between 30 minutes and 3.5 hours. For those randomized to the
handgrip training group, training sessions will last no more than 30 minutes.
Visits to the University of Windsor for testing will take place during week 1, week 5, and week 9 of this
study. You will be given a schedule of events for the study, to ensure your understanding and availability.
You will be notified via email and/or phone call for follow-up sessions.
POTENTIAL RISKS AND DISCOMFORTS
If you are assigned to the handgrip training group, you may experience tendonitis in the trained tendons,
however this risk is minimal if the exercise is properly performed. The blood pressure measurement
procedure is non-invasive, as is electrocardiography for acquiring heart rate. However, in rare instances, you
may experience numbness and/or tingling in the occluded limb while we are measuring your blood pressure
and/or a minor rash from the heart electrode stickers we use to measure your heart rate.
POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY
You may or may NOT experience a lower resting blood pressure by participating in this study.
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PAYMENT FOR PARTICIPATION
You will not receive payment for their participation in this study.
CONFIDENTIALITY
Any information that is obtained in connection with this study and that can be identified with you will remain
confidential and will be disclosed only with your permission.
To ensure anonymity of subjects, following consent, all participants will be assigned an identification
number. To ensure confidentiality, no mention of subject names will be used in any publication or
presentation, and participants will be identified only by their identification number on all collection tools
(electronic or otherwise). All paper data will be stored in a locked filing cabinet in the locked office of the
principal investigators (HK 133, Department of Kinesiology, University of Windsor), and all electronic data
will be stored in a locked laboratory (Applied Human Performance Laboratory, Department of Kinesiology,
University of Windsor). Information stored on computer will be password-accessible only, and will be
available only to the study investigators. With respect to final disposal, all paper records (including medical
questionnaires) will be shredded.
PARTICIPATION AND WITHDRAWAL
You can choose whether to be in this study or not. If you volunteer to be in this study, you may withdraw at
any time without consequences of any kind. You may also refuse to answer any questions you do not want
to answer and still remain in the study. The investigator may withdraw you from this research if
circumstances arise which warrant doing so.
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS
Subjects will have the option of receiving results from the study either by mail or email. Results will also be
posted on the University of Windsor’s Research Ethics Board (REB) website in April 2010.
Web address: http://www.uwindsor.ca/reb
Date when results are available: April 2010
SUBSEQUENT USE OF DATA
This data may be used in subsequent studies. As data will be collected under the subject’s identification
number, data used for ongoing studies will ensure the privacy of the subjects.
RIGHTS OF RESEARCH SUBJECTS
You may withdraw your consent at any time and discontinue participation without penalty. If you have
questions regarding your rights as a research subject, contact: Research Ethics Coordinator, University of
Windsor, Windsor, Ontario, N9B 3P4; Telephone: 519-253-3000, ext. 3948; e-mail: ethics@uwindsor.ca
SIGNATURE OF RESEARCH SUBJECT/LEGAL REPRESENTATIVE
I understand the information provided for the study “The effects of isometric handgrip exercise on postexercise hypotension and heart rate variability in individuals medicated for hypertension” as described
herein. My questions have been answered to my satisfaction, and I agree to participate in this study. I have
been given a copy of this form.
______________________________________
Name of Subject
______________________________________
Signature of Subject
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___________________
Date

SIGNATURE OF INVESTIGATOR
These are the terms under which I will conduct research.
_____________________________________
Signature of Investigator
Revised February 2008

____________________
Date
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Appendix G
Medical Questionnaire
Last Name________________________ First Name____________________________
Address________________________ City __________________ Province _________________
Sex (please circle): M

F

Height:_____________________ Weight: ___________________

Date of Birth_________ Home Phone # (
Month Year

) ______ Postal Code ________________

FOR EMERGENCY NOTIFY: Name______________________ Relationship_________________
Address____________________________________ Phone______________________________
Family Doctor's Name_____________________ Date of Last Physical _____________________
Month

Year

Please Check Yes or No:
Yes
1. Have you ever been hospitalized? --------------------------------------------------------------------------o
If yes, please specify?
________________________________________________________
Have you ever had surgery? ---------------------------------------------------------------------------------o
If yes, please specify?
________________________________________________________
2. Are you presently taking any medications or pills (including aspirin)?---------------------------- o
If yes, please specify?
________________________________________________________
Are you presently taking any vitamins or supplements?---------------------------------------------- o
3. Do you have any allergies (medicine, food, bees or other stinging insects)?------------------- o
If yes, please specify?
________________________________________________________
4. Have you ever passed out during or after exercise?--------------------------------------------------- o
Have you ever been dizzy during or after exercise?--------------------------------------------------- o
Have you ever had chest pain during or after exercise?---------------------------------------------- o
Do you have high blood pressure?------------------------------------------------------------------------- o
If yes, are you being treated for this condition?
________________________________________________________
Have you ever been told that you have a kidney problem? ----------------------------------------- o
Have you ever been told that you have joint instability? --------------------------------------------- o
Have you ever been told that you have a stomach problem? -------------------------------------- o
Have you ever been told that you have a heart problem? ------------------------------------------ o
Have you ever been told that you have a heart murmer? ------------------------------------------- o
Do you have a machine that regulated your heart beat? -------------------------------------------- o
Have you ever had racing of your heart or skipped heartbeats? ---------------------------------- o
Has anyone in your family died of heart problems or a sudden death before age 50? ------ o
5. Do you have any skin problems (itching, rashes, acne)? ------------------------------------------- o
If you get a cut, does it take you a long time to stop bleeding?------------------------------------- o
If you experience a blow to a muscle, to you bruise easily? ---------------------------------------- o
6. Do you have Diabetes? -------------------------------------------------------------------------------------- o
7. Do you have Asthma or any other breathing problems? -------------------------------------------- o
If yes, please specify?
________________________________________________________
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No
o

o

o

o
o

o
o
o
o

o
o
o
o
o
o
o
o
o
o
o
o
o

8.

Do you have any type of cardiovascular disease? ---------------------------------------------------- o
If yes, please specify?
________________________________________________________
9. Have you had any other medical problems (infectious mononucleosis, etc.)? -----------------o
10. Have you had any medical problems since your last physical? ------------------------------------o
11. Do you smoke? -------------------------------------------------------------------------------------------------o
Please explain any physical limitations that may prevent you from completing this study.
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________

125

o

o
o
o

Appendix H
________________________________________________________________________________

At HOME JOURNAL:
Subject ID:____________________________________________________________
Date

What was
your
maximum
contraction
value?

Did you
complete
two sets
with
each
hand?

Time you
took your
medication
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Have you
had any
medication
changes? If
yes, please
describe.

Have you
had any
dietary
changes? If
yes, please
describe.

Have you
had any
physical
activity
changes?
If yes,
please
describe.
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